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Abstract
So far, much attention has been paid to regulation of transcription. However, it has been
realized that controlled mRNA decay is an equally important process. To understand the
contributions of mRNA synthesis and mRNA degradation to gene regulation, we developed
Dynamic Transcriptome Analysis (DTA). DTA allows to monitor these contributions for both
processes and for all mRNAs in the cell without perturbation of the cellular system. DTA
works by non-perturbing metabolic RNA labeling that supersedes conventional methods for
mRNA turnover analysis. It is accomplished with dynamic kinetic modeling to derive the
gene-specific synthesis and decay parameters.
DTA reveals that most mRNA synthesis rates result in several transcripts per cell and cell
cycle, and most mRNA half-lives range around a median of 11 min. DTA can monitor
the cellular response to osmotic stress with higher sensitivity and temporal resolution than
standard transcriptomics. In contrast to monotonically increasing total mRNA levels, DTA
reveals three phases of the stress response. In the initial shock phase, mRNA synthesis and
decay rates decrease globally, resulting in mRNA storage. During the subsequent induction
phase, both rates increase for a subset of genes, resulting in production and rapid removal of
stress-responsive mRNAs. In the following recovery phase, decay rates are largely restored,
whereas synthesis rates remain altered, apparently enabling growth at high salt concentration.
Stress-induced changes in mRNA synthesis rates are predicted from gene occupancy with
RNA polymerase II. Thus, DTA realistically monitors the dynamics in mRNA metabolism
that underlie gene regulatory systems.
One of the technical obstacles of standard transcriptomics is the unknown normalization
factor between samples, i.e. wild-type and mutant cells. Variations in RNA extraction
efficiencies, amplification steps and scanner calibration introduce differences in the global
intensity levels. The required normalization limits the precision of DTA. We have extended
DTA to comparative DTA (cDTA), to eliminate this obstacle. cDTA provides absolute
rates of mRNA synthesis and decay in Saccharomyces cerevisiae (Sc) cells with the use
of Schizosaccharomyces pombe (Sp) as an internal standard. It therefore allows for direct
comparison of RNA synthesis and decay rates between samples.
cDTA reveals that Sc and Sp transcripts that encode orthologous proteins have similar syn-
thesis rates, whereas decay rates are five fold lower in Sp, resulting in similar mRNA con-
centrations despite the larger Sp cell volume. cDTA of Sc mutants reveals that a eukaryote
can buffer mRNA levels. Impairing transcription with a point mutation in RNA polymerase
(Pol) II causes decreased mRNA synthesis rates as expected, but also decreased decay rates.
Impairing mRNA degradation by deleting deadenylase subunits of the Ccr4–Not complex
causes decreased decay rates as expected, but also decreased synthesis rates.
In this thesis, we provide a novel tool to estimate RNA synthesis and decay rates: a quan-
titative dynamic model to describe mRNA metabolism in growing cells to complement the
biochemical protocol of DTA/cDTA. It can be applied to reveal rate changes for all kinds
of perturbations, e.g. in knock-out or point mutation strains, in responses to stress stimuli
or in small molecule interfering assays like treatments with miRNA or siRNA inhibitors. In
doing so, we show that DTA is a valuable tool for miRNA target validation. The DTA/cDTA
approach is in principle applicable to virtually every organism. The bioinformatic workflow
of DTA/cDTA is implemented in the open source R/Bioconductor package DTA.
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Part I
Introduction
The central dogma of molecular biology, first formulated by Francis Crick [46] (Figure 1), describes
the transfer of genetic information along the three important classes of biopolymers: deoxyribonu-
cleic acid (DNA), ribonucleic acid (RNA) and proteins. All three carry the important sequential
information whose heredity and constant availability are crucial for development and function of all
living organisms. The underlying biological processes, namely DNA replication, transcription into
RNA and translation into proteins, are the essential bridges between those three building blocks.
These processes are committed to transfer the genetic information in a faithful and deterministic
manner to ensure the precise and accurate function of the resulting biopolymer.
Figure 1: The central dogma of molecular biology describes the flow of genetic information along the three
important classes of biopolymers: DNA, RNA and protein. Adapted from [46].
RNA, one of the three important macromolecules, is a highly versatile compound. It functions in
the process of translation as rRNA and tRNA, contributes to the regulation of gene expression as
miRNA, siRNA or other non-coding RNA, or acts as a pure messenger: the mRNA. The underlying
mechanisms, with the eclectic and central roles they play in cell metabolism, are of high medical
interest, as they are associated with several diseases and defects [42, 69, 58].
1 The mRNA life cycle
The mRNA is a transient message of genetic information subject to nuclear synthesis and cytoplas-
mic degradation. These two opposing mechanisms control mRNA levels and consequently cellular
gene expression. The global and specific regulation of mRNA abundance can therefore either be
accomplished by alterations of synthesis or decay rates. Despite the spatial separation of mRNA
synthesis and degradation, there is evidence that these processes are coordinated [122, 123, 82].
mRNA turnover as well as its underlying mechanisms are a useful indicator for gene activity. High-
throughput methods for quantification of protein abundance [30, 150, 10] are not as feasible as
methods for mRNA quantification (Section 3.3). Nevertheless, changes in mRNA abundance were
shown to be correlated to changes in protein abundance [171, 21], which play a major role in cell
metabolism.
1.1 Synthesis of mRNA (The RNA polymerase II transcription cycle)
The most crucial enzyme in mRNA synthesis is the DNA-dependent RNA polymerase II (Pol II).
Pol II is a multi-subunit complex composed of 12 subunits, termed Rpb1p-12p. It is assembled in
the cytoplasm and then imported into the nucleus [210, 47], where it polymerizes mRNAs of all
protein coding genes against the corresponding DNA template. Eukaryotic transcription by Pol II
14
is orchestrated in four major phases, namely initiation, elongation, termination and re-initiation
(Figure 2). This circular arrangement and its underlying phases are highly regulated and require
a variety of specific proteins, including general transcription factors (GTF), negative and positive
cofactors, elongation factors, RNA processing factors and termination factors [79, 188]. Rpb1p, the
largest subunit of Pol II contains the unique carboxyl-terminal domain (CTD). It consists of multi-
ple, highly conserved heptapeptide tandem repeats (26 in yeast) [2, 43], which are phosphorylated
and dephosphorylated during transcription [29]. The CTD functions as a general platform to recruit
many regulatory factors involved in transcription, mRNA processing and histone modification [28].
Different CTD phosphorylation patterns were shown to be associated with different sets of regula-
tory factors required co-transcriptionally during different phases [156]. Control of Pol II activity is
specifically regulated at individual genes and is absolutely crucial for homeostasis of the cell [66].
Figure 2: The RNA polymerase II transcription cycle. Eukaryotic transcription by Pol II is orchestrated in
four major phases, initiation, elongation, termination and re-initiation. Adapted from [79, 188].
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1.1.1 Initiation and the general transcription factors
Transcription initiation by Pol II requires the general transcription initiation factors TFIIA, -B, -D,
-E, -F and -H. [179, 192, 203, 79]. Primarily, gene-specific factors (transcription activators) recognize
unique DNA elements, like TATA, BRE, Inr and DPE, located in the core promoter. Upstream acti-
vation sequences (UASs) can increase the expression of a gene. UASs are promoter proximal regions
and enhancer regions typically upstream of the transcription start site (TSS) of the gene. Sub-
sequently, nucleosome remodellers, chromatin-modifying enzymes and coactivators, like SWI/SNF,
INO80/SWR1, ISWI, NuA4, SAGA and Mediator, are recruited to remodel the chromatin archi-
tecture to ensure accessibility and promote the preinitiation complex (PIC) assembly at the core
promoter [35, 147, 202]. The PIC consists of the RNA Pol II and the factors TFIIA, -B, -D, -E,
-F and -H. These factors are required for transcription bubble formation, TSS scanning [106], and
initial synthesis of the nascent RNA molecule up to the +8 position after the DNA is unwound [79].
Thus, the basic state of a promoter is inactive and transcription must be initiated by several TFs
[186]. Gene-specific factors (transcription repressors) and chromatin-modifying enzymes can also
cause inaccessibility of regulatory sequences [202]. Promoters in eukaryotes can be classified into
two opposing categories regarding nucleosome occupancy, namely ’open’ and ’covered’, modulating
constitutive and highly regulated genes, respectively [62, 193]. Thus, regulation of chromatin struc-
ture is substantially linked to the regulation of Pol II transcription initiation. All these important
steps could, in principle, be rate limiting, adding an important layer that is prone to regulation [66].
1.1.2 Elongation and CTD phosphorylation
The transition from transcription initiation to early elongation happens at the +8 position when
Pol II gets stable on both the DNA and the growing RNA chain and leaves the promoter region.
This is known as promoter clearance or promoter escape and can also be rate limiting [66]. If not
terminated by abortive initiation, Pol II enters into the productive elongation phase. Then, the
capping enzymes are recruited and the nascent mRNA receives a 5’- cap when it reaches a chain
length of 25-30 nucleotides [207]. The nascent RNA is then synthesized by a stable elongation
complex resulting in a full-length RNA transcript [144, 128].
The phosphorylation level on the Ser2 residue of the Pol II CTD increases during the transcription
cycle. Simultaneously, it decreases on the Ser5 and Ser7 residues [28, 129]. This is referred to as
the CTD phosphorylation cycle which is associated with the transcription cycle. Different CTD
phospho-isoforms (CTD code) determine at each stage of the transcription cycle which particular
set of transcription, mRNA processing and chromatin-modifying factors have to be recruited [26,
55, 28, 131, 156, 159].
1.1.3 Termination and re-initiation
The final phase of the transcription cycle is reached when Pol II reaches the poly (A) site (pA
site) of the transcribed gene. The elongation factors are then replaced by termination factors [164].
At the pA site the transcript is cleaved off, Pol II transcribes a little further downstream and is
finally terminated [109, 104, 49]. During these steps, the mRNA receives a 3’-poly(A) tail. After
termination, transcription can be initiated again either by recruitment of the complete transcription
machinery to the promoter region or by facilitated re-initiation due to the promoter bound scaffold
complex [216]. This remainder of the initial transcription machinery, including TFIIA, -D, -E, -H
and Mediator, enables rapid PIC formation and thus efficient successive initiation. The underlying
processes of termination are highly regulated and coupled to RNA processing events, which often
occur far downstream of the poly (A) site [158, 27].
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1.2 Decay of mRNA (The cytoplasmic mRNA decay machinery)
The highly complex and elaborate mechanisms of mRNA transcription are of limited use without
equally precise control of mRNA degradation, which also plays a key role in gene regulation. After
transcription by Pol II accompanied by co-transcriptional 5’-end capping and 3’-end polyadenylation,
the mature mRNA is packaged and exported to the cytoplasm. In the cytoplasm mRNAs undergo
a primary round of translation and progressive deadenylation. Surveillance pathways can identify
and initiate exonucleolytic digestion of defective RNAs and ribonucleoprotein particles (RNPs): non-
stop decay (NSD) and no-go decay (NGD) deal with stalled ribosomes, and nonsense mediated decay
(NMD) handles mRNAs with premature translation termination codons (PTCs) [98, 130].
Figure 3: Cytoplasmic mRNA decay pathways. Surveillance pathways can identify and initiate degradation
of defective RNAs and RNPs, including non-stop decay (NSD), no-go decay (NGD) and nonsense medi-
ated decay (NMD). General cytoplasmic mRNA decay includes progressive deadenylation, decapping and
degradation by exonucleases from both ends. Adapted from [91, 209].
General cytoplasmic mRNA degradation begins with shortening or removal of the poly(A) tail
17
[31, 153]. Then, the mRNA is decapped and degraded by exonucleases from both ends (Figure 3).
Three major classes of RNA-degrading enzymes (ribonucleases or RNases) have been characterized:
endonucleases that cleave RNA internally, 5’-exonucleases and 3’-exonucleases that hydrolyze RNA
from the 5’- and 3’-end, respectively. Based on the large variety of RNases, which often possess
overlapping activities, redundancy is a general feature of the RNA degradation system, presumably
increasing the overall efficiency and robustness of degradation pathways.[91, 59, 152, 209].
1.2.1 Deadenylation and mRNA stability
The poly(A) tail of an mRNA is protected from exonucleases by poly(A)-binding proteins (PABPs/
Pab1p) which are recruited to the mRNA immediately after 3’-end polyadenylation during tran-
scription termination and cover the entire poly(A) stretch [126, 68]. PABPs in turn can interact
with the eukaryotic translation initiation factor 4F (eIF4F) that assembles on the 5’-cap of the
mRNA, facilitates initiation of translation [101] and effectively causes circularization of the mRNA
[209]. Progressive mRNA deadenylation occurs simultaneous to multiple rounds of translation. It is
accomplished by the Ccr4-Not complex, the major deadenylase in eukaryotes [209, 91]. Ccr4-Not is
composed of nine different subunits including Ccr4p and Pop2p (Caf1p), both with catalytic enzyme
activity. It can be recruited by mRNA-binding proteins, like Puf (Pumilio/FBF) proteins bound to
specific sequences in the 3-UTR, that control mRNA-specific rates of deadenylation [208, 75, 73, 194].
Cytoplasmic mRNA deadenylation can also be conducted by a conserved complex (PAN) consisting
of the Pan2p and Pan3p proteins. This was demonstrated in the absence of the predominant dead-
enylase Ccr4, where residual deadenylation is dependent on Pan2p [195]. PAN is also involved in
an initial phase of mRNA deadenylation, an early step in poly(A) metabolism that is required for
poly(A) tail length control. The poly(A) tail is shortened to 55− 75 nucleotides depending on the
individual mRNA species [24, 153]. Hence, eukaryotes own a highly sophisticated timing mechanism
to influence the dynamics of gene expression [209, 91]. Enhanced mRNA stability to allow efficient
translation versus destabilization due to shortening of the poly(A) tail inducing mRNA decay. In
yeast, cell-cycle-regulated genes possess generally short poly(A) tails, suggesting that deadenylation
also plays a crucial role in the regulation of their periodic expression [16, 149].
1.2.2 Decapping enzymes and degradation control
Early during elongation, eukaryotic mRNAs receive a protective 5’-cap structure. This 5’-cap must
be removed to render the 5’ end accessible for exonuclease degradation. Two types of decapping
enzymes were identified in eukaryotic cells: The scavenger decapping enzyme (DcpS) decaps short
5’-cap oligonucleotides to release m7GMP [118]. These capped oligonucleotides are probably decay
intermediates of 3’ to 5’ degradation by the cytoplasmic exosome, a large protein complex containing
multiple 3’ to 5’ exonucleases [199, 138]. The second decapping enzyme consists of two subunits,
Dcp1p and Dcp2p, with the latter as the catalytic subunit. Decapping by Dcp1p/Dcp2p follows
deadenylation and simultaneously triggers 5’ to 3’ exonucleolytic digestion by Xrn1p [140, 92], a
conserved 5’ to 3’ exonuclease. In summary, deadenylation is followed by one of two alternative
degradation pathways: 3’ to 5’ degradation by the cytoplasmic exosome, or decapping and 5’ to 3’
degradation by Xrn1 [209, 91, 153]. This process occurs co-translationally, enabling the ribosome to
complete translation before the mRNA is degraded [93]. Degradation is consequently controlled by
the competition of translation and decapping due to deadenylation regulation [153].
1.2.3 P-bodies
Recent evidence indicates that deadenylated, or translationally repressed mRNAs, deadenylation
factors, decapping factors, decapping activators and the 5’ to 3’ exonuclease Xrn1 colocalize within
cytoplasmic domains referred to as processing bodies (P bodies) [63, 177, 59]. mRNA transcripts
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associated with P bodies can either be subject to decay or return to translation. This suggests a post-
transcriptional regulation mechanism able to store mRNAs. The rates of translation and degradation
are thus influenced by the equilibrium between P bodies and translating polysomes. This might be
dependent on individual mRNA species, although the underlying structure and organization remains
still unclear [152].
1.3 miRNA induced silencing of mRNA targets
MicroRNA (miRNAs) are a class of small noncoding RNAs. Identified species of small RNAs,
including also small interfering RNAs (siRNAs) and Piwi-interacting RNAs (piRNAs), are distin-
guished via the differences in biogenesis, types of target regulation and RNA silencing pathways.
RNA silencing pathways are highly conserved in all eukaryotes from S.pombe to plants and ani-
mals and are probably linked competitively and collaboratively due to gene regulation [74, 212].
miRNAs mostly attracted attention as negative post-transcriptional regulators of gene expression
[4, 14, 197], e.g. thresholding in negative feed-back loops [37] and mediation of robustness against
environmental fluctuations or extrinsic and/or intrinsic perturbations [117]. On the contrary, recent
findings indicate, that miRNAs are able to up-regulate translation [200]. At least 30% of all protein
coding genes in animals are predicted to be regulated by miRNAs [23, 107, 115, 214]. miRNAs, as
well as other small RNAs, are characterized by their short length (∼ 21 − 23 nucleotides for miR-
NAs) and their association with the RNA-induced silencing complex (RISC). RISC complexes can
be recruited sequence-specific to its corresponding target mRNAs, predominantly to repress their
translation or stimulate their degradation. This is either accomplished by deadenylation and decap-
ping resulting in exonucleolytic degradation from both ends (partial sequence complementarity) or
directed site specific cleavage prior to digestion from the resulting accessable ends (perfect sequence
complementarity) [74, 91, 212].
1.3.1 miRNA biogenesis
miRNAs originate from long, hairpin-containing precursor transcripts, referred to as primary miR-
NAs (pri-miRNAs), which are in general transcribed by RNA Pol II polycistronically [114, 113].
Biogenesis proceeds in the following sequential steps: Primarily, the pri-miRNAs are cleaved in
the nucleus by the RNase III endonuclease Drosha, together with its double-stranded RNA-binding
domain (dsRBD) partner Pasha [112, 50], into ∼ 60− 70 nucleotide long hairpin pre-miRNAs. Sec-
ondly, the Ran-GTP dependent nucleo/cytoplasm transporter Exportin-5 carries the pre-miRNAs
to the cytoplasm. In the cytoplasm, the pre-miRNAs are cleaved by a second RNase III endonucle-
ase, Dicer [95, 103], and its dsRBD partner Loqs, into ∼ 21 − 23 nucleotide long double-stranded
duplexes, containing both the mature miRNAs and their complementary strands [83, 12, 74].
1.3.2 Post-transcriptional repression by miRNAs
After processing, the double-stranded duplex is loaded into the RNA-induced silencing complex
(RISC). RISC is a multi-protein complex including catalytic components of the Argonaut (Ago)
protein family [51]. RISC incorporates the mature miRNA strand, while the complementary strand
(often referred to as miRNA*) is expelled from the complex. The active RISC complex can subse-
quently target mRNAs with sequence complementarity to the seed region, a limited region at the 5’
end of the miRNA, contributing the majority of the binding energy [5, 81]. miRNAs bind in gen-
eral to the 3’-untranslated regions (3’-UTRs) of their corresponding target mRNAs. Consequently,
single-stranded miRNAs function as a guide for Ago proteins to localize their mRNA targets, re-
press translation and initiate degradation [74, 83, 23, 116, 115, 110]. The miRNA loaded RISC is
recruited to target mRNAs in two of the following ways: complete sequence complementarity of the
binding regions leads to site-specific endonucleolytic cleavage by Ago. The resulting RNA fragments
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are subsequently degraded by Xrn1 and the exosome from the accessable 5’ and 3’ ends. In most
cases, however, miRNAs target mRNAs with only partial sequence complementarity. The short seed
region can in turn lead to a large number of different mRNA targets regulated by a single miRNA
[173, 9]. Translation is repressed and the mRNA is deadenylated and decapped by Ccr4-NOT [61]
and Dcp1/Dcp2, respectively. The remaining mRNA is subsequently degraded by Xrn1 and the
exosome from the 5’ and 3’ ends [60, 212]. The mechanism of mRNA target regulation by miRNAs
consequently depends on the extent of complementarity to the binding regions [91, 74, 83].
Figure 4: miRNA induced post-transcriptional silencing of mRNA targets (blue). The RNA-induced silenc-
ing complex (RISC) can be recruited to a corresponding targeted mRNA to either repress its translation or
stimulate its degradation. Adapted from [57, 91]
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2 Exponential decay and half-life of mRNA populations
It is a reasonable assumption to model cytoplasmic mRNA decay as a first order reaction, i.e. the
rate of the reaction depends on the concentration of a reactant. This is presumably not entirely
true as the enzyme-catalyzed reactions of degradation are thought to be tightly regulated with the
adaption of gene expression programs to certain stimuli, but it remains to be a rational choice for a
mixture of cells [111, 90, 205, 77, 176, 171, 52].
Figure 5: Exponential decay and half-life of mRNA populations. Exemplary illustration showing the relation
of the total mRNA amount Tt at timepoint t, the decay rate λ, the half-life t1/2 and the mean life time τ .
A quantity T decays exponentially if it declines at a rate proportional to its value [145]. This can
be stated as in the following differential equation. Units of concentration per units of time
dT
dt
= −λT (1)
with time t and decay rate λ. The decay rate hence gives the proportion of the number of total
mRNA transcripts that are decayed in the first unit of time. The solution to this equation yields
Tt = T0e
−λt (2)
with the initial value T0 = T (0) (Figure 5). As a consequence, Equation (2) defines a relation
between the initial value T0, the current value Tt at time t and the decay rate λ. Equation (2) can
be normalized to give a probability density. By this means, we obtain the exponential distribution
function, which is characterized by 1λ as its expected value [19]. This subsequently enables us to
derive the average time an mRNA remains stable via
τ =
1
λ
. (3)
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τ is called the mean life time or exponential time constant. It is often referred to as scaling time,
which can be seen by rearranging Equation (2) with respect to (3):
Tt = T0e
−t/τ (4)
Consequently, τ is the time at which the initial amount of mRNAs is reduced to e−1 = 1/e times its
initial value. The most common characteristic of exponential decay is the half-life t1/2 defined as
t1/2 =
log2
λ
= τ log2 . (5)
Given this equation, we can restate Equation (2) to yield an alternative formula
Tt = T02
−t/t1/2 (6)
This intuitive equation allows the interpretation, that after a period of n · t1/2 minutes the amount
of mRNAs is reduced to 1/2n times its initial value.
3 Conventional methods for mRNA turnover analysis
mRNA decay rates have previously been determined using transcriptional arrest [90, 205, 77, 176,
18, 78, 162, 174, 215, 7, 143] and then monitoring genome-wide mRNA degradation over time.
The intensity of each mRNA species relative to that observed in a wild-type cell can be used to
derive a measure for mRNA decay, applying the usual first-order exponential decay model (Section
2). The assumption, however, that mRNA decay is unaffected after inhibition of the transcription
machinery, is invalid. Transcriptional arrest can be induced with a temperature-sensitive mutation
in RNA polymerase II (Section 3.1) or via treatment with chemical inhibitors (Section 3.2). This
requires a perturbing heat shock, i.e. cells have to be shifted to the nonpermissive temperature of
37°C, or is inherently cell invasive and also shows induced heat shock response genes [1, 33, 70, 178].
Both methods induce a general stress response of the cell which leads to a strong stabilization of all
transcripts probably due to mRNA decay compensation of the decreased mRNA synthesis (Sections
15.5, 16). Furthermore, it can influence the regulatory mechanisms of mRNA degradation, which
lead to different decay profiles, exhibiting differential internal degrees of stabilization. (Section
16.3). Additionally, both approaches are not capable of measuring newly transcribed mRNA as an
estimator for transcriptional activity, i.e. synthesis rates.
3.1 Blocking transcription: the rpb1-1 mutant strain
The rpb1-1 mutant strain was first isolated by Nonet et al. [148] as a yeast conditional mutant. It
carries a temperature-sensitive mutation in the largest subunit Rpb1p of RNA polymerase II. It was
shown that this functionally defective RNA polymerase II mutant rapidly ceases mRNA synthesis
when shifted to the nonpermissive temperature of 37°C [148]. As a consequence, the rpb1-1 mutant
strain can be used to measure mRNA decay rates via monitoring the remaining mRNA populations
after the temperature shift. The intensity of each mRNA species relative to the initial amount is
then used to derive a rate of degradation, assuming first-order exponential decay (Section 2).
3.2 Chemical inhibition of transcription
There are several chemicals that allow transcriptional arrest: e.g. 1,10-phenanthroline, 6-azauracil,
thiolutin, ethidium bromide, cordycepin and actinomycin-D. These treatments indeed, are applicable
to all kinds of organisms [77, 18, 78, 162, 174, 215, 7, 143] in comparison to the rpb1-1 mutant strain
(Section 3.1). The calculation of the decay rate, however, is analogous (Sections 3.1, 2).
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3.3 Gene-expression profiling
The analysis of mRNA transcript abundance has been preferably accomplished with high resolution
profiling on microarrays over the last decades [105]. These methods allow genome-wide molecular
read-outs to analyze gene expression. Genes are represented by short oligonucleotide sequences
(probes, 25-mers) identical to parts of the corresponding DNA sequence (Affymetrix® GeneChip®
Yeast Genome 2.0 Array, [120, 211]). Several probes distributed along the DNA sequence of a
certain gene are combined to a probeset. mRNA samples are amplified via reverse transcription
into cDNA, fluorescently labeled during transcription into cRNA and subsequently hybridized to
the corresponding probes that are immobilized on a solid surface on the microarray. Afterwards,
the fluorescence of the bound DNA:cRNA hybrid is detected in a scanning procedure to yield a
numerical read-out that is assumed to be proportional to the initial mRNA concentration in the
sample [84, 85, 86, 180] (Section 16.1, Figure 44). In order to quantify non-specific hybridization,
each probe (perfect match probe) is complemented with a mismatch probe with a single nucleotide
mismatch at position 13. Mismatch probes can be used for background correction of the perfect
match fluorescence signal, particularly its numerical value [105].
4 Dynamic Transcriptome Analysis (DTA)
mRNA levels in a cell are the consequence of two opposing mechanisms, namely nuclear mRNA
synthesis and cytoplasmic mRNA degradation. These individual contributions keep mRNA levels in
a dynamic equilibrium and can be monitored by Dynamic Transcriptome Analysis (DTA) [52, 64,
6, 136, 187, 168]. A technique that allows us to understand the contributions of both processes to
gene regulation in a non-disruptive way.
Figure 6: 4sUTP is modeled into the crystal structure of a Pol II transcribing complex (PDB code: 116H).
The thiol group at position 4 can form a hydrogen bond with the DNA template strand (blue). Nascent
mRNA is in red. Taken from [136].
4.1 Non-perturbing RNA labeling (in yeast)
The nucleoside analog 4-thiouridine (4sU) is taken up by eukaryotic cells and incorporated into
mRNA during Pol II transcription [133] (Figure 6). The thiol-labeled newly transcribed RNA can
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then be isolated by biotinylation and purification with streptavidin-coated magnetic beads [36, 52].
Although this approach is generally applicable to mammalian, insect, and plant cells, RNA labeling
is not directly applicable to yeast. The nucleoside analog 4sU is readily taken up by cells of a broad
range of eukaryotic organisms and is efficiently incorporated into their newly transcribed RNA. This
can be used to metabolically label and isolate newly transcribed RNA from total cellular RNA with
high specificity [102, 52]. In the fission yeast S.pombe, expression of the human equilibriative nucleo-
side transporter (hENT1) enables cellular uptake of the nucleoside analog 5-bromo-2’-deoxyuridine,
resulting in labeling of DNA during replication [88]. This transporter can also mediate efficient up-
take of 4sU in the budding yeast S.cerevisiae, and thus allow efficient RNA labeling at a level similar
to that generally achieved in mammalian cells. This subsequently facilitates efficient separation of
total cellular RNA into newly transcribed and pre-existing RNA. It is however also possible to use
4-thiouracil (4tU) instead of 4sU for RNA labeling in S.cerevisiae [141] and S. pombe, because it is
taken up by the cells without expression of a nucleoside transporter [136]. 4tU labeling does also
not affect normal cell physiology [136] and even allows growth of yeast in complete medium (YPD)
instead of selective medium (SD), which is needed for selection due to the nucleoside transporter
(hENT1).
4.2 DTA
The experimental setup for DTA requires culturing cells in the presence of a labeling substrate (e.g.
4-thiouridine (4sU) or 4-thiouracil (4tU)) for a certain amount of time (Section 4.1). During a short,
non-perturbing RNA labeling pulse, cells incorporate 4sUTP into newly transcribed RNA instead of
UTP. The cells are subsequently lysed and total cellular RNA is extracted. The newly transcribed
labeled RNA is biotinylated and purified with streptavidin-coated magnetic beads [36, 52]. This
setup yields three types of RNA fractions: total cellular RNA, pre-existing unlabeled RNA (flow-
through) and newly transcribed labeled RNA (Figure 7). The quantification of these fractions
through gene expression profiling on microarrays (Section 3.3) or RNAseq is used to estimate mRNA
synthesis and decay rates with our novel statistical approach on a genome-wide scale, assuming
exponential decay (Sections 2, II, 15). Monitoring mRNA degradation without transcriptional arrest
and additionally measuring mRNA synthesis simultaneously in a single experimental setting is the
outstanding advantage of DTA.
Figure 7: Scheme of metabolic mRNA labeling in yeast. Nascent mRNA is labeled with 4-thiouridine (4sU)
and thiol-specifically biotinylated following cell lysis and preparation of total cellular mRNA. Fractionation
into pre-existing and nascent mRNA is achieved with streptavidin beads. Adapted from [136].
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4.3 cDTA (comparative DTA)
One of the major drawbacks in conventional transcriptomics is the unknown normalization factor
between samples, i.e. wild-type and mutant cells. Variations in lysis and RNA extraction efficiencies,
amplification steps in the protocol and the mandatory scanner calibration introduce differences in
the global intensity levels of the measurements (Section 18.4). The estimation of the normalization
factors limits the precision of DTA. We have extended DTA to comparative DTA (cDTA) to eliminate
this obstacle (Section 16). This is accomplished by mixing an internal normalization standard of the
distantly related fission yeast S. pombe (Sp) cells to samples of wild-type or perturbed S. cerevisiae
(Sc) cells in the defined ratio of 3:1 (Sc:Sp) after cell counting (Figure 8). The resulting cell mixture is
subsequently lysed, total mRNA extracted, labeled RNA purified, and the RNA mixture is quantified
on a microarray that contains probes for both Sc and Sp transcripts (Affymetrix® GeneChip®
Yeast Genome 2.0 Array, Section 3.3). A large culture of Sp cells was labeled to generate a stock
and eliminate errors due to variations in the standard. cDTA provides absolute rates of mRNA
synthesis and decay in S. cerevisiae (Sc) cells with the use of S. pombe (Sp) as an internal standard.
It therefore allows for direct comparison of RNA synthesis and decay rates between samples.
Figure 8: The Sc cells are labeled by adding 4tU into the media whereas Sp cells are labeled by adding 4sU.
The cells are then counted. Sc cells from different experiments are mixed with always the same amount of
labeled Sp cells from a single batch. Cells are then lysed, mRNA is extracted, biotinylated, and labeled mRNA
separated. Microarrays containing probes against both Sc and Sp transcripts are then used to quantify both
total and labeled mRNA. Adapted from [187].
5 Aims and scope of this thesis
The regulation of transcription has been intensively studied for a considerable time. On the other
hand, mRNA decay has only recently been noticed to be an equally important process of gene reg-
ulation. To understand the contributions of mRNA transcription and stability to gene regulatory
processes, methods must be developed to measure the rates for both processes and for all mR-
NAs in the cell. Furthermore, the rates of mRNA synthesis and decay must be measured without
perturbation of the cellular system, and changes in these rates must be monitored to follow a cel-
lular response. This cannot be achieved by standard transcriptomics, which only measures mRNA
abundance. Synthesis rates can be measured by genomic run-on (GRO) [67, 155], but this requires
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sarkosyl treatment that inhibits cellular processes. Decay rates can be measured after blocking tran-
scription with inhibitors [111, 77, 18, 78, 162, 174, 215, 7, 143] but this is inherently cell invasive
(Section 3.2). In addition, decay rates can be measured with a temperature-sensitive yeast strain
[90, 205, 77, 176], but this requires a perturbing heat shock (Section 3). Unperturbed RNA synthesis
and decay rates can be obtained via metabolic RNA labeling and kinetic modeling [36, 102, 52, 64]
(Section 4). An additional limitation of standard transcriptomics is the unknown normalization
factor between samples, i.e. wild-type and mutant cells. Variations in RNA extraction efficiencies,
amplification steps and scanner calibration introduce differences in the global intensity levels.
The aim of this thesis was the development of a quantitative, dynamic model that describes mRNA
metabolism in growing cells to supplement the biochemical part of the DTA approach (Section
4), which is based on genetically facilitated uptake of 4sU resp. 4tU, metabolic RNA labeling
and microarray measurements which eliminate the obstacle of incomparability between different
samples (Section 4.3) and allow the estimation of synthesis and decay rates simultaneously in a
single experimental setting. The whole DTA/cDTA approach can monitor changes in synthesis and
decay rates at unprecedented sensitivity and temporal resolution. It is a highly valuable tool for
the analysis of dynamic changes in mRNA metabolism and a method that can provide quantitative
data for modeling complex gene-regulatory systems, which is needed to provide new insights and
to uncover misleading drawbacks of traditional methods. Furthermore, DTA/cDTA can be applied
to reveal rate changes for all kinds of perturbations, e.g. knock-out or point mutation strains,
responses to stress stimuli or small molecule interfering assays like treatments with miRNA or
siRNA inhibitors. In doing so, we show that DTA is a valuable tool for miRNA target validation.
The DTA/cDTA approach is in principle applicable to virtually every organism. The bioinformatic
workflow of DTA/cDTA is implemented in the open source R/Bioconductor package DTA [170] as
a part of this thesis.
6 Software
6.1 Statistical computing and graphics
The R programming environment [160] was used to carry out data handling, parameter estimation,
statistical calculation and graphical display of this thesis. R is available as Free Software under the
terms of the Free Software Foundation’s GNU General Public License in source code form. It runs
on a wide variety of UNIX platforms, Windows and MacOS.
6.2 Implementation and availability
A major part of the workflow of this thesis is implemented in the open source R/Bioconductor
package DTA [170]. The DTA package delivers straightforward methods to estimate mRNA synthesis
and decay rates from pre-processed microarray or RNA-Seq measurements that are obtained via the
DTA/cDTA protocol. It is capable of a thorough bias correction, detailed visualisation of quality
control aspects and proper handling of comparative or time-series DTA data. The DTA package also
allows to simulate all kinds of gene regulatory events that underlie the control of synthesis or decay
of a gene or geneset. The implemented simulation methods are also quite useful to explore the limits
of the model that builds the basis of the interplay between synthesis and decay. Additionally it can
be used to assess minimum data quality requirements and is equipped with a proper error model
able to give confidence regions of the estimated rates. The DTA package satisfies the high standard
of the Bioconductor framework, regarding documentation and usability. It can therefore be easily
incorporated in R workflows for pre-processing. Further statistical analysis of the results can readily
be carried out by other methods within the R/Bioconductor programming environment. DTA is
implemented in R version 2.15 [160] and part of Bioconductor version 2.10 [72]. To download and
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install DTA and all its dependencies refer to
http://www.bioconductor.org/packages/release/bioc/html/DTA.html.
DTA builds upon the R package LSD [169]. LSD is a high-level plotting package, which provides the
ability to depict all kinds of data in a suitable fashion and offers a plethora of variations to unveil
its underlying structure. To download and install LSD and all its dependencies refer to
http://cran.r-project.org/web/packages/LSD/index.html.
6.3 Usage and application
For a more detailed explanation and example R code of the DTA package [170], refer to [168] and
the package vignette
http://www.bioconductor.org/packages/release/bioc/vignettes/DTA/inst/doc/DTA.pdf.
For plotting examples of the LSD package [169], we refer to the LSD.demo.tour() and the reference
manual
http://cran.r-project.org/web/packages/LSD/LSD.pdf.
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Part II
Methods
7 A model for mRNA synthesis and degradation
In the following, we propose a model that complements the experimental DTA approach (Section
4). It accounts for exponential cell growth and for variations in RNA extraction efficiencies. It also
corrects for differences in the fraction of newly synthesized mRNAs that escape labeling:
Let r ∈ R be a sample. At time t = 0, we start mRNA labeling. During the labeling period, 4sUTP
is integrated into newly synthesized mRNA (Section 4.1). At the timepoint tr, when the mRNA is
extracted, the total mRNA amount Cgr(tr) of gene g in the sample r is composed of the amount
Bgr(tr) of (pre-existing) mRNA that has been synthesized before t = 0 and the amount Agr(tr) of
mRNA that has been newly synthesized after t = 0,
Cgr(tr)︸ ︷︷ ︸
total RNA
=
Agr(tr)︸ ︷︷ ︸
newly synthesized mRNA
+
Bgr(tr)︸ ︷︷ ︸
pre-existing mRNA
(7)
Let Nr(tr) denote the number of cells in the sample r at time tr. The cells are grown and harvested
during mid-log phase, i.e. the cell number follows an exponential law with growth rate,
α =
log(2)
CCL
≥ 0 (8)
with the cell cycle length CCL. This means
dNr(t)
dt
= αNr(t) (9)
and therefore
Nr(tr) = Nr(0)e
αtr . (10)
α is often refered to as the dilution rate, i.e. the reduction of concentration due to the increase of
cell volume during growth. Say we have a cellular expression level mg = mg(t) (transcripts of gene
g per cell), then
Cgr(t) = mg(t)Nr(t) (11)
and hence
dCgr(t)
dt
= mg(t)
dNr(t)
dt
+
dmg(t)
dt
Nr(t) (12)
= mg(t)αNr(t) +
dmg(t)
dt
Nr(t)
=
(
mg(t)α+
dmg(t)
dt
)
Nr(t).
We assume that the mRNA population of a gene g decays exponentially at a (relative) rate given by
λg = λg(t) (Section 2). This means that the amount of λg(t)Cgr(t) molecules is degraded during the
interval of time dt. We further assume that the mRNA population of a gene g is synthesized at an
absolute rate per cell given by µg = µg(t). Hence the amount of µg(t)Nr(t) molecules is synthesized
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during dt. In summary, the total mRNA amount follows the following differential equation:
dCgr(t)
dt
= µg(t)Nr(t)− λg(t)Cgr(t) (13)
= µg(t)Nr(t)− λg(t)mg(t)Nr(t)
= (µg(t)− λg(t)mg(t))Nr(t).
Using Equations (12) and (13), we get
(µg(t)− λg(t)mg(t))Nr(t) =
(
mg(t)α+
dmg(t)
dt
)
Nr(t) (14)
and hence
µg(t) = mg(t) (α+ λg(t)) +
dmg(t)
dt
. (15)
Additionally, we assume that the pre-existing mRNA population of a gene g decays exponentially
at the same (relative) rate λg = λg(t). This means for the pre-existing mRNA fraction that
dBgr(t)
dt
= −λg(t)Bgr(t). (16)
Consequently, the newly synthesized mRNA fraction can be given by
dAgr(t)
dt
=
dCgr(t)
dt
− dBgr(t)
dt
= µg(t)Nr(t)− λg(t)Agr(t). (17)
with respect to Equation (7).
8 A model for constant synthesis and decay rates
The differential equations proposed in Section 7 can be solved without loss of generality (see Section
12). The DTA derived measurements (Sections 15, 16), however, suggest to simplify our model in
order to increase the feasibility of rate extraction. To that end, we assume genes to have a (time
averaged) constant synthesis rate µg and decay rate λg during 4sU/4tU labeling, i.e. µg(t) = µg and
λg(t) = λg are given as constants. Nevertheless, it allows for changes in synthesis and decay rates in
distinct labeling time windows, e.g. time course measurements. For the newly synthesized mRNA,
this means
dAgr(tr)
dt
= µgNr(tr)− λgAgr(tr) = µgNr(0)eαtr − λgAgr(tr). (18)
The solution of this differential equation yields
Agr(tr) = ce
−λgtr +
µgNr(0)e
αtr
α+ λg
(19)
with an initial value Agr(0) = 0, and so
0 = c+
µgNr(0)
α+ λg
. (20)
This finally leads to
Agr(tr) =
µgNr(0)
α+ λg
[
eαtr − e−λgtr
]
(21)
and therefore
µg =
Agr(tr)(α+ λg)
Nr(0)
[
eαtr − e−λgtr
] . (22)
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For the total mRNA, we get
dCgr(tr)
dt
= µgNr(tr)− λgCgr(tr) = µgNr(0)eαtr − λgCgr(tr). (23)
The solution of this differential equation yields
Cgr(tr) = ce
−λgtr +
µgNr(0)e
αtr
α+ λg
(24)
with
c = Cgr(0)−
µgNr(0)
α+ λg
. (25)
This in turn leads to
Cgr(tr) = Cgr(0)e
−λgtr +
µgNr(0)
α+ λg
[
eαtr − e−λgtr
]
(26)
and finally
Bgr(tr) = Cgr(tr)−Agr(tr) = Bgr(0)e−λgtr (27)
with Bgr(0) = Cgr(0). From (22) and (26) we can deduce
Cgr(tr) = Cgr(0)e
−λgtr +Agr(tr) (28)
and rearrange it as follows
Cgr(tr)−Agr(tr) = Cgr(0)e−λgtr . (29)
Consequently
e−λgtr =
Cgr(tr)−Agr(tr)
Cgr(0)
(30)
and hence
λg = −
1
tr
log
[
Cgr(tr)−Agr(tr)
Cgr(0)
]
(31)
or likewise
λg = −
1
tr
log
[
Bgr(tr)
Cgr(0)
]
. (32)
As λg is assumed to remain constant in the above derivation, its value will be an average value along
the labeling period.
9 mRNA turnover in steady state
In the following, we assume that the cells exhibit constant growth under constant environmental
conditions. In particular, this implies that the amount of each mRNA population is constantly
diluted by cell growth over time, being the result of a dynamic equilibrium of a constant mRNA
synthesis and decay, i.e. steady state. In this case we assume genes to have a (time averaged)
constant cellular expression level mg during 4sU/4tU labeling. Thus, Equation (11) simplifies to
Cgr(tr) = mgN(tr). (33)
This leads to
Cgr(tr) = mg(0)Nr(0)e
αtr (34)
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as mg(t) = const. = mg(0) = mg and hence
Cgr(tr) = Cgr(0)e
αtr . (35)
Equation (31) can therefore be written as
λg = −
1
t
log
[
Cgr(tr)−Agr(tr)
Cgr(tr)e−αt
]
. (36)
As a consequence
λg = −α−
1
t
log
[
1− Agr(tr)
Cgr(tr)
]
(37)
or
λg = −α−
1
t
log
[
Bgr(tr)
Cgr(tr)
]
. (38)
Steady state mRNA levels can now be derived from Equations (13) and (12):
dCgr(tr)
dt
= µgNr(tr)− λgCgr(tr) = mg(tr)αNr(tr)
yields
mg(0) =
µg
α+ λg
.
As a result
Cgr(0) =
µgNr(0)
α+ λg
(39)
gives the total mRNA level achieved by a dynamic equilibrium of a constant mRNA synthesis and
decay. In this special case µg can be stated as
µg = mg(0)(α+ λg) (40)
by implication.
Note: Without any disturbance of the cells, the synthesis rates µg and decay rates λg pertaining
to the mRNA level of a transcript g are considered constant if averaged over a cell cycle period.
Although there are transcripts whose synthesis rates vary considerably during the cell cycle, this
assumption is valid as we measure a large, unsynchronized population of cells. The same argument
holds if transcription happens in bursts, i.e. in each cell, periods of high transcriptional activity
(many mRNA copies in a few minutes) are followed by periods of complete inactivity.
10 Adaption to the DTA measurement process
Variations in lysis and RNA extraction efficiencies, amplification steps in the protocol and the
mandatory scanner calibration introduce discrepancies between the real concentrations of the mRNA
fractions Agr(tr), Bgr(tr) and Cgr(tr) and the measured intensity levels of the labeled mRNA Lgr(tr),
unlabeled mRNA Ugr(tr) and total mRNA Tgr(tr). Ideally, these fractions would respectively equal
each other. The amount Lgr(tr) of labeled mRNA for instance is proportional to the amount of
labeled mRNA Agr(tr) at the time tr of sampling,
Lgr(tr) = arAgr(tr) , (41)
with an unknown array-specific constant ar. Analogously, the measured amounts Tgr(tr) and Ugr(tr)
depend on the actual amounts Cgr(tr) and Bgr(tr) respectively via
Tgr(tr) = crCgr(tr) , (42)
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and
Ugr(tr) = brBgr(tr) = br (Cgr(tr)−Agr(tr)) (43)
with unknown array-specific constants cr and br.
There might also be differences in the fraction of newly synthesized mRNAs that escape labeling.
This fraction is larger for shorter RNAs, and depends on the uracil content of the mRNA and the
4sU/4tU labeling efficiency (Section 11.1, Figure 9). Let plabr be the probability that during the
labeling process of sample r, a UTP is replaced by 4sUTP and afterwards attached to a biotin
molecule. Let lgr represent the fraction of newly synthesized mRNAs of gene g in sample r that
are biotinylated. We assume that all biotinylated mRNAs are captured by the streptavidin-coated
magnetic beads. Denote by #ug the number of uracil residues present in the mRNA corresponding
to gene g. The probability that the mRNA of gene g containing #ug uracils is not captured at
all (assuming independence of events for each uracil position) is (1 − plabr )#ug . Conversely, the
probability that a newly transcribed mRNA with #ug uracils is captured in the labeled fraction is
lgr = l(p
lab
r ,#ug) = 1− (1− plabr )#ug (44)
lgr is thus the probability that at least one UTP is replaced by 4sUTP and afterwards attached to
a biotin molecule. Accordingly, we have to correct Equations (41),(42) and (43) to that effect. As a
consequence we have the dependencies:
Lgr(tr) = lgrarAgr(tr) , (45)
Tgr(tr) = crCgr(tr) (46)
and
Ugr(tr) = br (Cgr(tr)− lgrAgr(tr)) . (47)
(48) can also be stated as
Ugr(tr) = brugrBgr(tr) (48)
where ugr gives the increase of pre-existing mRNAs by newly synthesized mRNAs of gene g in sample
r that are not biotinylated. With Equation (47) and (48) we have
Cgr(tr) = lgrAgr(tr) + ugrBgr(tr) , (49)
and therefore
ugrBgr(tr)−Bgr(tr) = Agr(tr)− lgrAgr(tr) (50)
with respect to Equation (7). Solving for ugr yields
ugr = 1 +
Agr(tr)
Bgr(tr)
(1− plabr )#ug (51)
and thus
ugr
(
plabr ,
br
ar
, ug
)
= 1 +
br
ar
(1− plabr )#ug if
ugrLgr(tr)
lgrUgr(tr)
= 1 . (52)
The proportional constants then relate as follows
cr
ar
=
br
ar
1 + brar
if also
Lgr(tr)
lgrTgr(tr)
= 1 . (53)
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11 Parameter Estimation
In summary, our model contains the parameters
Θ =
{
α, plabr , ar, br, cr, lgr, ugr, λgr, µgr | r ∈ R, g ∈ G
}
.
The two sources of experimental bias, namely the parameters ar, br, cr that account for multiplicative
bias introduced via sample preparation, and the parameter plabr that models the labeling bias (Figure
9), are part of the model and thus allow for an implicit normalization.
Methods for RNA quantification are often prone to measurement errors. Genes that exhibit residual
expression, for instance, lead to noisy measurement signals. On the other hand, genes that show
very high expression tend to saturate their corresponding probes on microarrays (see Section 3.3
and Figure 44). All these measurements could lead to flawed parameters, and hence all genes that
are considered valid for the parameter estimation are aggregated in Greliable.
Since the doubling times of the cells are usually known or can be measured accurately, α is given by
α = log 2/CCL. We propose a 4-step procedure for the identification of the remaining parameters
in Θ:
11.1 Estimation of the labeling probability pr
The estimation of the sample-related parameters {plabr , ar, br, cr | r ∈ R} is done on the basis of the
reliable genes Greliable. The quotient of observed total and labeled mRNA levels can be written as
Lgr
Tgr
=
lgrarAgr(tr)
crCgr(tr)
= lgr
ar
cr
[
1− e−tr(α+λg)
]
. (54)
The first equation follows by (45) and (46), the second by (26) and (21). We can visualize this
dependence conveniently by plotting #ug versus log
Lgr
Tgr
(see Figure 9). If all decay rates were equal,
all points would lie on the graph given by the relationship of #ug versus log lgr + log arcr . The scatter
around this graph is caused by measurement errors and differences in decay rates. We can also
calculate the quotient
Ugr
Tgr
=
brugrBgr(tr)
crCgr(tr)
= ugr
br
cr
[
e−tr(α+λg)
]
. (55)
This equation follows by (46) and (47). We will predominantly use Equation (54) for the estimation
of plabr and the synthesis and decay rate estimates (see Section 13, Figure 28) due to our short
labeling duration. Taking logs in Equation (54) and rearranging terms, we obtain
log
Lgr
Tgr
= log
ar
cr
+ log l(plabr ,#ug) + log
[
1− e−tr(α+λg)
]
. (56)
This equation holds for all genes. plabr < 0.95 implies that for #ug > 700 say, the approximation
log(lgr) ≈ 0 is almost exact, as (1− plabr )#ug is a monotonic sequence with
lim
#ug→∞
(1− plabr )#ug = 0
and (1− plabr )700 < 2.5 · 10−16. Hence Equation (54) simplifies to
log
Lgr
Tgr
= log
ar
cr
+ log
[
1− e−tr(α+λg)
]
for #ug > 700 . (57)
If we furthermore assume that there is no systematic dependence of the decay rate λg on the uracil
content of g, we can model the Lg/Tg ratio with respect to Equation (57) as
log
Lg
Tg
= log
[
1− (1− plab)#ug
]
+ εg
33
Figure 9: The number of uracils #ug is plotted versus the log-ratio of Lgr and Tgr for two replicates
of S.cerevisiae at a labeling time of 6 minutes. The points of the scatterplot are colored according to the
(estimated) point density in that region [169]. The labeling bias parameter pestr = 0.0048 and pestr = 0.0055
imply that approximately every 208th resp. 182th uracil residue is replaced by 4sU. mRNAs which contain
less than 500 uracil residues (approx. 72% of all S.cerevisiae mRNAs) are not captured efficiently.
with i.i.d errors εg, g ∈ Greliable. Thus, we estimate asymptoteL/Tr by setting
asymptoteL/Tr = median
{
log
Lgr
Tgr
| g ∈ Greliable, #ug > 700
}
. (58)
Given Equation (58), it follows that a robust estimate of plabr can be obtained by finding an optimal
fit to (56) (see Figure(9)), for all g ∈ Greliable with #ug < 500. So we optimize the value of plabr ,
r ∈ R, by minimizing the l1-loss function
pestr = argmin
q∈(0, 1)
loss(q) with loss(q) =
∑
g∈G,#ug<500
∣∣∣∣ logLgrTgr − log lgr(q, ug)− asymptoteL/Tr
∣∣∣∣ (59)
Here, 500 is an upper bound that ensures that the measurements are still responsive to changes in
#ug.
11.2 Estimation of the ratio of labeled to unlabeled mRNA br
ar
Notice that for the purpose of synthesis and decay rate estimation it is sufficient to merely determine
the quotients brar ,
ar
cr
or brcr instead of the individual constants ar, br and cr. As described in Section
(11.1), we can use Equation (55) to estimate
asymptoteU/Tr = median
{
log
Ugr
Tgr
| g ∈ Greliable, #ug > 700
}
(60)
and consequently optimize the value of brar , r ∈ R, by minimizing the l1-loss function
br
ar
est
= argmin
q∈(0, 5)
loss(q) with loss(q) =
∑
g∈G,#ug<500
∣∣∣∣ logUgrTgr − log ugr(plabr , q,#ug)− asymptoteU/Tr
∣∣∣∣ .
(61)
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This dependence is shown in Figure 10.
Figure 10: The number of uracils #ug is plotted versus the log-ratio of Ugr and Tgr for two replicates
of S.cerevisiae at a labeling time of 6 minutes. The labeling bias parameter pestr = 0.0048 and pestr =
0.0055 estimated via the labeled mRNA fraction Lgr as described in Section (11.1) reveal the ratio of newly
synthesized to pre-existing mRNA given by brar
est
.
11.3 Estimation of the ratio of labeled to total mRNA ar
cr
and unlabeled to total
mRNA br
cr
In order to determine the quotients arcr or
br
cr
, we simply multiply Equations (54) and (55) by the
inverse of those quotients and add them up to obtain
cr
ar
Lgr
Tgr
+
cr
br
Ugr
Tgr
= 1 or Tgr(tr) =
cr
ar
Lgr +
cr
br
Ugr (62)
Equation (62) describes a plane {(Tgr, Lgr, Ugr) | Tgr = crarLgr +
cr
br
Ugr} in the 3-dimensional Eu-
clidean space. As the observed variables have measurement errors on both sides of Equation (62),
we perform a total least squares regression [76] of Tgr versus Lgr and Ugr, which accounts for a
Gaussian error in the dependent variable Tgr and, in contrast to ordinary linear regression, also
in the independent variables Lgr, Ugr. The total least squares regression minimizes the orthogonal
distance of the data points to the inferred plane as opposed to a linear regression, which minimizes
the distance of Tgr to the inferred linear function of Lgr and Ugr. We use a robust version of total
least squares regression. After the first run, we remove the data points with the 5% largest residuals
to avoid the potentially detrimental influence of outlier values on the parameter estimation process
(see Figure (11) and (12)). Note that the estimation steps proposed in Section 11.2 and 11.3 are
separately sufficient to calculate the synthesis and decay rate parameters (see Section 11.4), as the
proportional constants brar ,
ar
cr
or brcr relate to each other according to Equation (53).
35
Figure 11: Two rounds of total least squares regression (tls) for two replicates of S.cerevisiae at a labeling
time of 6 minutes. The resulting plane is colored green. The x-axis is chosen as the orthogonal projection
on Lgr. The y-axis is the normal of the plane. The second round of tls is performed without the 5% largest
residuals of the 1st round, depicted in red. Red planes indicate maximal residuals.
Figure 12: Two rounds of total least squares regression (tls) for two replicates of S.cerevisiae at a labeling
time of 6 minutes in a different representation. The resulting plane is shown exactly from the side and is
indicated by the green line. As in Figure (11), the x-axis is chosen as the orthogonal projection on Lgr, but
in logarithmic scale. The y-axis is the normal of the plane. The 5% largest residuals of the 1st round are
depicted in red. Red lines indicate maximal residuals.
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Figure 13: Dependency of the estimated decay rate on the term 1 − crarlgrLgr/Tgr for two replicates of
S.cerevisiae at a labeling time of 6 minutes. Reasonable decay rates can only be obtained for 1− crarLgr/Tgr
values between the two dashed lines. Right plot shows the median of both replicates.
11.4 Estimation of the decay rate λgr
To estimate the decay rate λgr, we use Equation (31) to yield
λgr = −
1
tr
log
[
Tgr(tr)− crlgrarLgr(tr)
Tgr(0)
]
(63)
for the dynamic case, and Equation (37) to deduce
λgr = −α−
1
tr
log
[
1−
cr
lgrar
Lgr(tr)
Tgr(tr)
]
(64)
for the steady state case. It is also possible to estimate the decay rate λg in an alternate way
according to Equation (38) as
λgr = −α−
1
tr
log
[
cr
ugrbr
Ugr(tr)
Tgr(tr)
]
. (65)
All three Equations (63), (64) and (65) are subject to logarithmic calculation. The decay rate λg
can not be calculated in cases where the quotient in the logarithm is ≤ 0. If this quotient reaches
a certain size, the Equations (63), (64) and (65) will yield negative decay rates which are then
discarded. This circumstance is assessed in Figure (13). Each reasonable λg estimate can be used
to calculate the half-life estimate
t1/2gr =
log(2)
λgr
. (66)
All measured samples r are combined to yield estimates
λestg = median {λgr | r ∈ R} , (67)
and
test1/2gr = median
{
t1/2gr | r ∈ R
}
. (68)
The reproducibility of replicate measurements can be investigated by comparison of the quotient in
the logarithm of Equations (63), (64) and (65), see Figure (14).
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Figure 14: Pairwise heatscatter plots of the ranks of the respective 1− crarlgrLgr/Tgr value distributions for
two replicates of S.cerevisiae at a labeling time of 6 minutes are shown in the upper panel. The lower panel
shows the respective Spearman correlations.
11.5 Estimation of the synthesis rate µgr
To estimate the synthesis rate µgr, we use Equation (22) to yield
µgr =
cr
lgrar
Lgr(tr)(α+ λgr)[
eαtr − e−λgrtr
] . (69)
since Nr(0) is set to 1, these values are on an arbitrary scale. For each replicate experiment r, the
number mgr of mRNA transcripts per cell of gene g is proportional to its total mRNA intensity
value Tgr, mgr = drTgr. Assuming a total number of #mRNAs mRNAs per cell, this means that
#mRNAs =
∑
g∈G
mgr = dr ·
∑
g∈G
Tgr , (70)
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and therefore
dr =
#mRNAs∑
g∈G Tgr
. (71)
Together with Equation (40), we may estimate µgr as
µrescaledgr =
mgr
Tgr
µgr · CCL = drµgr · CCL (72)
in molecules per cell and cell cycle. All measured samples r are combined to yield estimates
µestg = median {µgr | r ∈ R} . (73)
To get an overview of the correlations of the measured and derived value distributions, see Figure
(15). As expected, the synthesis rate is in good agreement to the labeled mRNA fraction. The
labeling bias was properly corrected: According to the assumption that the distribution of decay
rates does not depend on the mRNA length, there is no dependence of any estimate to the number
of uracil residues. Most surprisingly, the gene expression levels and mRNA half-lives correlate only
weakly. We did extensive checks to ensure that this observation is not an artefact of the estimation
procedure (Supplementary Section 13.5 [136]).
Figure 15: The pairwise correlations between the labeled expression values Lgr, total expression values Tgr,
the number of uracils per transcript #ug and the estimated synthesis rate µgr, decay rate λgr and half-life
t1/2gr is given in a color-coded image plot for the gene-wise median of two replicates of S.cerevisiae at a
labeling time of 6 minutes .
11.6 Estimation of the relative 4sUTP incorporation efficiency
We define three probabilities associated with the mRNA labeling process: The incorporation effi-
ciency pinc is the probability that a 4sUTP nucleotide is incorporated into a nascent mRNA instead
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of a UTP. It is the product of the relative 4sUTP concentration (relative to the UTP concentration)
in the nucleus and the relative affinity of Pol II for 4sUTP (compared to UTP). Note that the relative
affinity does not change if the transcription machinery is not impaired. Since we have no handle to
separate these two quantities, we merge them into pinc. Secondly, the capture efficiency pcap is the
probability for a 4sUTP which is included into a mRNA of being biotinylated, captured and recov-
ered from the streptavidin-coated magnetic beads. Third, the probability that both events occur,
assuming independence, is plab = pinc · pcap, the labeling efficiency (Section 10, Equation (44)). A
labeling efficiency substantially below 1 introduces a uracil-dependent labeling bias by letting newly
transcribed, uracil-poor mRNA have a higher probability to escape labeling (Section 11.1). All three
probabilities are sample- and strain-specific. The labeling efficiency can be estimated directly from
cDTA data (Section 4.3). We can use cDTA to conclude from plab to the relative incorporation
efficiencies. Note that for a sample x,
pcapx (Sc) = p
cap
x (Sp) (74)
since the labeled Sc and Sp mRNA from one sample are processed simultaneously. Moreover,
pincx (Sp) = p
inc
y (Sp) (75)
for two experiments x, y, since we use a common Sp standard for all experiments. Then,
plabx (Sc)
plabx (Sp)
=
pincx (Sc) · p
cap
x (Sc)
pincx (Sp) · p
cap
x (Sp)
(74)
=
pincx (Sc)
pincx (Sp)
. (76)
Consequently, the relative incorporation efficiencies of two samples x and y is
pincx (Sc)
pincy (Sc)
(75)
=
pincx (Sc)
pincx (Sp)
·
pincy (Sp)
pincy (Sc)
(76)
=
plabx (Sc)
plabx (Sp)
·
(
plaby (Sc)
plaby (Sp)
)−1
. (77)
Equation (77) can be used to estimate the variation in the relative incorporation efficiency, a varia-
tion estimate is given by
v = std.dev.
(
pincx1 (Sc)
pincx2 (Sc)
, xj∈replicates of group j
)
. (78)
12 Model properties and limitations
A simulation environment can help to assess the properties of our model proposed in Section (7).
We can simulate the impact of altered synthesis and decay rates on the resulting total mRNA level
(Figure 16). For that purpose, we can solve the stated differential equations (13),(17) and (16)
without loss of generality as
Cgr(t) = e
´ t
0 −λg(ξ1)dξ1
[
Cgr(0) +
ˆ t
0
Nr(ξ2)µg(ξ2)e
´ ξ2
0 λg(ξ1)dξ1dξ2
]
(79)
for the total mRNA,
Agr(t) = e
´ t
0 −λg(ξ1)dξ1
[
Agr(0) +
ˆ t
0
Nr(ξ2)µg(ξ2)e
´ ξ2
0 λg(ξ1)dξ1dξ2
]
(80)
for the newly synthesized mRNA and
Bgr(t) = Bgr(0)e
´ t
0 −λg(ξ1)dξ1 (81)
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for the pre-existing mRNA. Say we start labeling at time t0, the amount of pre-existing mRNA at
time t can be calculated as
Bgr(t, t0) = Cgr(t0)e
´ t
t0
−λg(ξ1)dξ1 (82)
with Bgr(t0) = Cgr(t0). Equation (82) allows a general notation that emphasizes the start of the
labeling process. For the newly synthesized mRNA at time t we consequently have
Agr(t, t0) = Cgr(t)−Bgr(t, t0) , (83)
as Agr(t) = Cgr(t)−Bgr(t), see Equation (7).
Given the steady state level of a certain mRNA population (39), it is possible to regulate the
total mRNA amount to a new level either by alteration of the synthesis rate or the decay rate.
According to our model (Section 7), it is not feasible for the cell to lower the total mRNA amount
by reducing synthesis (Figure 17) nor induce it by reduction of decay (Figure 18). It is further much
more efficient to accomplish mRNA level alterations directly. Up-regulation through synthesis and
down-regulation through decay (Figure 17 and 18). As expected, regulation of mRNA levels by the
opposing manipulation of both mechanisms seems also not to be required. In contrast to a very
efficient way to reduce levels by means of decay which is mediated almost directly, up-regulation by
induction of synthesis needs to be stimulated in a much higher fold to efficiently boost total mRNA
levels (Figure 19).
The assumptions met in the proposed model (Section 7) might not be entirely correct. Nevertheless
it is reasonable to assume that the synthesis rate affects the total mRNA level linearly (zero order
reaction). It is also rational to model decay as an exponential process (first order reaction). However
this does not take into account, that the mechanism of decay might also be regulated by a specific
recruitment of the decay machinery. Another drawback of the previous discussed model is, that
decay can affect newly synthesized transcripts as soon as they are produced. This however does not
account for the delay given by the time a transcript needs to be exported to the cytoplasm, nor does
it include the possibility of RNA binding proteins with stabilizing or destabilizing effect.
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Figure 16: Plot shows a time course example of a single simulated gene given the course of the decay rate
λg(t) = const. = 0.07 (shown in the 2nd panel in blue) and the synthesis rate µg = µg(t) (shown in the
1st panel in red) which is down-regulated from 20 to 4 in a sigmoidal manner at 6 min and subsequently
up-regulated to the initial level at 36 min. The 3rd and 4th panel show the development of the total, newly
synthesized and pre-existing mRNA in black, red and blue respectively. The 4th panel shows the development
of all three fractions for labeling durations of each 6 min. The respective expression readouts are indicated
by colored circles.
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Figure 17: Plot shows a time course example of two simulated genes given the course of the synthesis rate
µg = µg(t) (shown in the 1st panel) and the decay rate λg = λg(t) (shown in the 2nd panel). One gene is
8-fold down-regulated in the synthesis rate for 40 min with a constant decay rate (red). The other one is
8-fold up-regulated in the decay rate for 40 min with a constant synthesis rate (blue). The 3rd panel shows
the development of the total mRNA for both down-regulation types in the respective color. The black dots
indicate total mRNA resulting from a 8-fold down-regulated synthesis rate and a 8-fold up-regulated decay
rate at the same time.
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Figure 18: Plot shows a time course example of two simulated genes given the course of the synthesis rate
µg = µg(t) (shown in the 1st panel) and the decay rate λg = λg(t) (shown in the 2nd panel). One gene is
8-fold up-regulated in the synthesis rate for 40 min with a constant decay rate (red). The other one is 8-fold
down-regulated in the decay rate for 40 min with a constant synthesis rate (blue). The 3rd panel shows the
development of the total mRNA for both up-regulation types in the respective color. The black dots indicate
total mRNA resulting from a 8-fold up-regulated synthesis rate and a 8-fold down-regulated decay rate at
the same time.
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Figure 19: Plot shows a time course example of two simulated genes given the course of the decay rate
λg(t) = const. = 0.09 (shown in the 2nd panel in blue) and the synthesis rate µg = µg(t) (shown in the 1st
panel in red) which are both up-regulated 8-fold (blue, red) and with a short additional 16-fold induction at
the very beginning. The 3rd panel shows the development of the total mRNA for both up-regulation types
in the respective color.
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13 Error assessment and propagation
13.1 Regularized standard deviation
In the following we derive an error model which intends to assign confidence regions to the estimated
parameters from Section 11. The parameters are estimated from microarray measurements (Section
3.3) and are thus prone to errors. Given that methods should be cost- and time-saving, the number
of replicate measurements is often dramatically reduced. A low number of replicate measurements,
however, is not sufficient to derive a good estimate for the sample variance. This typically requires at
least 10 samples, which would make experiments prohibitively expensive and time-consuming. The
following error model is intended to regularize the gene-wise empirical standard deviation according
to the overall distribution of standard deviations on a microarray. It appears for typical microarray
measurements that the variance of measured RNA intensities is a function of the intensity (Figure
20). This dependence can be modeled via a LOESS fit (see Section 18.1) to give the gene-specific
mean deviation. The empirical standard deviation can then be regularized given the distribution of
all gene-wise sample deviations for replicate measurements, i.e. the empirical standard deviation of
a gene is corrected by its expected deviation from the gene-specific mean deviation. It is reasonable
to assume that the error for the expression values on the log scale is normally distributed [94]:
logxg ∼ N (µxg , σ2xg) (84)
with gene-specific parameters µxg , the sample mean and σxg , the standard deviation. We further
assume that the gene-specific standard deviation σxg follows a gamma distribution (Figure 20)
σxg ∼ Γ(
f(µxg)
2
ν
,
ν
f(µxg)
) (85)
with scale
θ = ν/f(µxg) (86)
and shape
k = f(µxg)
2/ν (87)
where f(µxg) is the gene-specific mean deviation obtained by the LOESS fit and ν is the variance
of the gamma distribution derived from the LOESS residual distribution. ν is obtained via the
method of moments (Section 18.2). To that end, the LOESS residual distribution is shifted, so that
the smallest residual resembles 0. The gamma distribution in Equation (85) with its associated
parameters, i.e. scale θ = ν/f(µxg) and shape k = f(µxg)2/ν, then possesses the gene-specific mean
deviation as expected value and the array-specific deviation ν as its variance (Histogram and red
distribution in Figure 20).
We can further state the likelihood of the log(expression) values {xgi | i = 1, . . . , n} (n gives the
number of replicates), to be explained by the parameters µxg and σxg , and simultaneously that the
parameter σxg itself originates from a gamma distribution with parameters scale θ = ν/f(µxg) and
shape k = f(µxg)2/ν :
P (xgi;µxg , σxg , ν) =
n∏
i=1
N (xgi;µxg , σ2xg)Γ(σxg ;
f(µxg)
2
ν
,
ν
f(µxg)
) (88)
=
n∏
i=1
1
σxg
√
2π
e
−
(xgi−µxg )
2
2σ2xgi
1
θk
1
Γ(k)
(σxg)
k−1e−
σxg
θ )
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The parameter µxg can be obtained from the sample population as the sample mean. As the
parameter ν can be derived from the LOESS residual distribution via the method of moments
(Section 18.2), we can derive a regularized standard deviation by finding
σregularizedxg = argmax
σxg
[
P (xgn;µxg , σxg , ν)
]
. (89)
Figure 20: Left: Figure shows the gene-wise mean log(expression) µTg (x-axis) versus its standard deviation
σTg (y-axis), and the corresponding LOESS curve (black line) (Section 18.1). The red density (resp. his-
togram) shows the gamma distributed residuals (LOESS). Based on the variance of the red distribution the
gene-specific standard deviation can be regularized if the number of replicate measurements is low. Right:
The empirical versus the regularized standard deviation.
13.2 Sampling and confidence regions
The previously obtained regularized standard deviation can subsequently be used to calculate con-
fidence regions of the extracted rates with a sampling approach. It is inevitable to investigate how
the initial measurement error propagates numerically through the formulae of our model (Section
7). The regularized standard deviation is used instead of the empirical standard deviation in order
to derive robust estimates of confidence intervals of the estimated rates. We can asses the reliability
of half-life, synthesis and decay rate estimates, given a set of parameters: The mean expression µLg
and µTg for the labeled and total fraction (bias corrected via lgr and rescaled via
ar
cr
), the respective
regularized standard deviations σregularizedLg and σ
regularized
Tg
, the underlying labeling duration t and
the cell cycle length CCL. Given the assumption of normal distributed errors for the total expression
on the log scale, we construct
T1, ... , TN ∼
iid
N (µTg , σ
regularized
Tg
) (90)
with N realizations of the random variable Ti, giving the log(expression) µTg + εT with εT ∼
iid
N (0, σregularizedTg ). Analogously to Equation (90), we construct
L1, ... , LN ∼
iid
N (µLg , σ
regularized
Lg
) (91)
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with N realizations of the random variable Li, giving the log(expression) Lµ + εL with εL ∼
iid
N (0, σregularizedLg ). We further set α = log(2)/CCL according to our model in Section 7. The
rate calculation then follows Equations (64), (68) and (69): The decay rate
λi = −α−
1
t
log
[
1− Li
Ti
]
, (92)
the half-life
t1/2i =
log(2)
λi
(93)
and the synthesis rate
µi =
Li(α+ λi)
[eαt − e−λit]
. (94)
Given the sample populations
λPg = (λi)i=1,...,N , t
P
1/2g
=
(
t1/2i
)
i=1,...,N
and µPg = (µi)i=1,...,N , (95)
we are able to assign confidence regions to the underlying rate estimates given the interquantile
ranges
Cλg =
[
Q0.025(λ
P
g ), Q0.975(λ
P
g )
]
,
Ct1/2g =
[
Q0.025(t
P
1/2g
), Q0.975(t
P
1/2g
)
]
,
and
Cµg =
[
Q0.025(µ
P
g ), Q0.975(µ
P
g )
]
.
They are derived by using the 2.5 and 97.5 percentiles of the respective sample populations. Hence,
these limits yield 95% confidence regions.
13.3 Parameter dependent error propagation
We are able to assess how a given error is propagated by the rate estimation under varying exper-
imental and gene-specific parameters, given the framework in Section 13.2. For feasibility reasons,
we will only assess how the gene-specific mean deviations f(µTg) and f(µLg) propagate accord-
ing to changes in the underlying parameter set. The gene-specific mean deviations are modeled
as the function giving the dependence of the log(expression) deviation among replicates and the
log(expression) mean (Section 13.1). The gene-specific mean deviation observed for 12 wild-type
replicates of S.cerevisiae is shown in Figure 21.
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Figure 21: Plot shows a smoothed LOESS fit curve giving the relationship of the mean log(expression) value
Tµ, Lµ on the x-axis and the standard deviation σ(Tµ), σ(Lµ) on the y-axis for the total mRNA fraction
(black) and the labeled mRNA fraction (red). 12 replicate measurements of wild type S.cerevisiae after a 6
min labeling period were used to calculate a standard deviation (sd) and the mean intensities for each gene.
As initialization, we set the intensity dependent standard deviation according to the mean total
log(expression) values Tµ = 8 by evaluating the respective LOESS function (Section 18.1), that is
σ(Tµ) = f(Tµ) = 0.12 . (96)
Likewise, we choose the following fixed parameters: The median decay rate λµ = log(2)/15, a labeling
duration of tµ = 6 minutes and a corresponding ratio of labeled to total mRNA
aµ
cµ
(tµ) = 0.15.
Additionally, we set the cell cycle length to CCL = 90 minutes, the labeling probability plabµ = 0.005
and the number of uracils to #uµ = 1000.
In order to obtain comparability among different scales we build the coefficient of variation, which is
defined as cv = standard deviation/mean. This transformation reveals that the relative error given
by the coefficient of variation decreases with the mean expression value (Figure 20).
We can slightly alter the proposed sampling approach from Section 13.2 according to the following
modifications: In order to obtain the given decay rate λµ, we set
offsetµ = Lµ − Tµ = log
[
lµ(pµ,#uµ) aµ
cµ
(
1− e−tµ(α+λµ)
)]
(97)
to define
Lµ = Tµ + offsetµ . (98)
This determines Lµ and all remaining parameters. We can use Tµ, Lµ and σ(Tµ), σ(Lµ) as the mean
and standard deviation for Equations (90) and (91). The rate calculation then follows Equations
(64), (68) and (69): The decay rate
λi = −α−
1
tµ
log
[
1−
cµ
lµaµ
Li
Ti
]
, (99)
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the half-life
t1/2i =
log(2)
λi
(100)
and the synthesis rate
µi =
cµ
lµaµ
Li(α+ λi)[
eαtµ − e−λitµ
] . (101)
As a measure for the relative error, we build the coefficient of variation for the decay rate
cvλ =
sd {λi | i = 1, ... , N}
mean {λi | i = 1, ... , N}
, (102)
the half-life
cvt1/2 =
sd
{
t1/2i | i = 1, ... , N
}
mean
{
t1/2i | i = 1, ... , N
} (103)
and the synthesis rate
cvµ =
sd {µi | i = 1, ... , N}
mean {µi | i = 1, ... , N}
. (104)
Note that, the sample mean and standard deviation - though they are extremely common measures
for location and dispersion - do not reflect the skewness and kurtosis of the underlying distribution.
Nevertheless, it is a sufficient measure in this case as the resulting distributions are approximately
Gaussian (validation not shown).
In the following, we assessed the influence of one or two varying parameters on the relative error
of the estimators synthesis rate, decay rate and half-life, leaving the other parameters fixed. As
expected, the relative error observed in half-life, synthesis and decay rate estimates also decreases
with the magnitude of the underlying expression value (Figures 22, 24 and 25). This motivates a
lower intensity cut off (Section 11). This behavior, however, is not the case among a typical range
of half-lives. As it turns out, the relative error of decay rates and half-lives increases almost linearly
with the magnitude of the given half-life t1/2µ , except for relative strong errors for very short half-lives
(Figures 23 and 24). Reliable half-life estimates can therefore predominantly be obtained between
5 and 70 minutes. This phenomenon is explained by the increasing labeled to total ratio Lµ/Tµ as
the decay rate rises, giving the error in the labeled fraction a stronger influence, see Equation (99).
Surprisingly, the relative error in the synthesis rate almost vanishes, downsized by the decreasing
given decay rate λµ. (Figure 23 and 25, Equation (101)).
It is also possible to estimate the decay rate according to Equation (65). This allows to compare both
alternate estimators for the decay rate (Section 11.4). It turns out that the decay rate estimator
based on the ratio Lµ/Tµ tends to exhibit smaller relative errors for short labeling durations tµ,
whereas the decay rate estimator based on Uµ/Tµ is prone to smaller relative errors for long labeling
durations tµ. The relative error increases as the ratio Lµ/Tµ or Uµ/Tµ approaches 1 (Figure 28).
This justifies the use of Equation (54) instead of Equation (55), as we predominantly use a labeling
time of 6 minutes.
50
Figure 22: Plot shows the coefficient of variation for total expression Tµ, labeled expression Lµ, the decay
rate λµ, the half-life t1/2µ and the synthesis rate µµ on the y-axis over the typical range of expression values
(log-scale) on the x-axis leaving the other parameters fixed, i.e. the decay rate λµ, the ratio of labeled to
total aµcµ , the labeling duration tµ, the cell cycle length CCL, the labeling probability pµ and the number of
uracil residues #uµ. Dashed line indicates the lower intensity cut off (Section 11).
Figure 23: Plot shows the coefficient of variation for total expression Tµ, labeled expression Lµ, the decay
rate λµ, the half-life t1/2µ and the synthesis rate µµ on the y-axis over the typical range of half-lives on the
x-axis leaving the other parameters fixed. Dashed lines indicate that reliable half-life estimates range from 5
to 70 minutes.
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Figure 24: Plot shows the coefficient of variation for the decay rate λµ on the z-axis over the typical range
of expression values (log-scale) on the y-axis and the typical range of half-lives on the x-axis leaving the other
parameters fixed.
Figure 25: Plot shows the coefficient of variation for the synthesis rate µµ on the z-axis over the typical
range of expression values (log-scale) on the y-axis and the typical range of half-lives on the x-axis leaving
the other parameters fixed.
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Figure 26: Plot shows the coefficient of variation for the decay rate λµ on the z-axis over the labeling
duration on the y-axis and the typical range of half-lives on the x-axis leaving the other parameters fixed.
Figure 27: Plot shows the coefficient of variation for the synthesis rate µµ on the z-axis over the labeling
duration on the y-axis and the typical range of half-lives on the x-axis leaving the other parameters fixed.
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Figure 28: Plot shows the coefficient of variation for the decay rate λµ calculation based on the ratio Lµ/Tµ
(blue) and based on the ratio Uµ/Tµ (red) on the y-axis over the labeling duration tµ on the x-axis leaving
the other parameters fixed. Dashed line indicates the labeling time predominantly used in our experiments.
This justifies the use of Equation (54) instead of Equation (55).
14 In silico simulation
Simulations, based on the proposed model, are of major importance. They can be used to assess if
the designed parameter estimation process works properly and does not introduce further biases. In
general, a realistic true parameter set is chosen or created as a gold standard. Noise can subsequently
be added to the true data set. Bias and variance can then be assessed by regaining the true parameter
set in order to anticipate the prediction quality of the chosen model.
14.1 Steady state case
To examine the estimation procedure described in Section 11, we can simulate measurements of the
labeled Lgr, unlabeled Ugr and total fraction Tgr for a given number of genes g ∈ G and replicates
r ∈ R by providing a random half-life distribution, a random total mRNA distribution and a random
sample of corresponding size giving the number of uracil residues. The latter is drawn randomly
from an F distribution
ug ∼
iid
F(5, 10) · 350 (105)
with degrees of freedom 5 and 10 and subsequently scaled by 350 to resemble a real distribution of
uracil numbers observed in S.cerevisiae, S.pombe or D.melanogaster (data not shown). Half-lives
are drawn randomly from an F distribution
t1/2gr ∼iid F(15, 15) · 12 (106)
with degrees of freedom 15 and 15 and subsequently scaled by 12 to resemble our right skewed
observed distribution, see Section 15. This can in turn be used to yield the decay rate
λgr = log(2)/t1/2gr (107)
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The true amount of log(total mRNA) at timepoint t = 0 is drawn randomly from a normal distri-
bution with mean equal to 8 and standard deviation equal to 1. This gives a microarray-typical
intensity distribution in log-scale
γgr ∼ N (8, 1) (108)
and can subsequently be used to get absolute intensity levels
Cgr(0) = e
γgr . (109)
The following steps are now analogous to our model (Section 7):
Cgr(tr) = Cgr(0)e
αtr (110)
where α is given by α = log(2)/CCL. tr as well as CCL can be chosen arbitrarily in a reasonable
manner. Tgr(t) can be build from Cgr(t) by adding noise:
Tgr(tr) = Cgr(tr) + ε
total
gr with ε
total
gr ∼
iid
N (0, 0.125 · Cgr(tr)) (111)
whereN (0, 0.125·Cgr(tr)) denotes a normal distribution with mean equal to 0 and standard deviation
equal to 0.125 ·Cgr(tr). This is consistent with the fact that the variance of measured data increases
with intensity (data not shown). We set
cr :=
median {Tgr(tr) | g ∈ G}
median {Cgr(tr) | g ∈ G}
(112)
which can be derived from Equation (42). The true amount of newly synthesized mRNA, called
Agr(t) in our model, is constructed as follows:
Agr(tr) = Cgr(tr)(e
αtr − e−λgrtr) (113)
To obtain Lgr we include a labeling bias lgr as in (44), and add noise:
Lgr(tr) = lgrAgr(tr) + ε
labeled
gr with ε
labeled
gr ∼
iid
N (0, 0.125 · lgrAgr(tr)) (114)
We set
ar :=
median {Lgr(tr) | g ∈ G}
median {lgrAgr(tr) | g ∈ G}
(115)
which can be seen from Equation (41). Further we rescale Lgr to the same range as Tgr:
Lgr =
Lgr ·median {Tgr(tr) | g ∈ G}
median {Lgr(tr) | g ∈ G}
(116)
This strategy simulates amplification steps in the biochemical protocol and scanner calibration. We
further need the true amount of unlabeled mRNA:
B̃gr(tr) = Cgr(tr)− lgrAgr(tr) (117)
and again we add noise
Ugr(tr) = B̃gr(tr) + ε
unlabeled
gr with ε
unlabeled
gr ∼
iid
N (0, 0.125 · B̃gr(tr)) (118)
and also rescale Ugr to the same range as Tgr:
Ugr =
Ugr ·median {Tgr(tr) | g ∈ G}
median {Ugr(tr) | g ∈ G}
(119)
55
Finally, we set
br :=
median {Ugr(tr) | g ∈ G}
median
{
B̃gr(tr) | g ∈ G
} (120)
We generated an artificial data set consisting of duplicate measurements for 5000 genes with a
labeling duration of t = 6 and 12 minutes each. The cell cycle length CCL was set to 150 minutes,
and the labeling probability plabr was set to 0.005.
Figure 29: Comparison between true (= simulated) and estimated parameters in an absolute manner and
on the basis of their ranks: synthesis rate µg, decay rate λg and half-life t1/2g . The rightmost plots shows
the log-ratio of the estimated vs. the true parameters in a histogram. The mode is the maximum of the
corresponding density indicated by the blue line. As a measure for a systematic deviation from zero (depicted
in green) we calculated the mean relative deviation (MRD). The MRD is defined by mean
(
|τestg −τ
true
g |
τtrueg
)
with
τ = µ, λ or t1/2.
The true coefficients, that are to be recovered in (62) by the total least squares regression, are
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now just the quotients of the individual constants ar, br and cr. We then applied our estimation
procedure (Section 11) to fit the parameters arcr ,
br
cr
, brar , pr, λgr, t1/2gr and µgr see (Figure 29).
Figure 30: Comparison between true (= simulated) and estimated parameters obtained without labeling
bias correction: synthesis rate µg, decay rate λg and half-life t1/2g . The rightmost plots shows the log-ratio of
the estimated vs. the true parameters in a histogram. The mode is the maximum of the corresponding density
indicated by the blue line. As a measure for a systematic deviation from zero (depicted in green) we calculated
the mean relative deviation (MRD). The MRD is defined by mean
(
|τestg −τ
true
g |
τtrueg
)
with τ = µ, λ or t1/2. The
points in the scatterplots should be located directly and in a symmetric manner around the blue line to
represent a good fit. The histogram is broader than in the results of our procedure, and it additionally shows
a systematic bias towards longer half-lives and lower synthesis rates.
Omission of the labeling bias correction can lead to skewed estimates. To demonstrate this, we also
used our simulated data to recompute the true coefficients without correcting for the labeling bias.
There is a clear tendency to underestimate the decay rates as the transcripts with a uracil number of
less than 500 make up almost 2/3 of all mRNAs. Assuming a labeling efficiency of plab = 0.005 as has
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been estimated in our data. Figure 30 shows that omitting labeling bias correction results in half-life
estimates that are severely systematically biased towards longer half-lives and lower synthesis rates.
20% of the mRNA half-lives in our experiment would have been biased more than twofold (Figure
31). The labeling bias is smaller for higher labeling efficiencies.
Figure 31: Plot shows #ug vs. bias (log2(estimated decay/true decay)) curves, each curve corresponding
to a given half-life (5, 10 or 20 min) and labeling efficiency (pr = 0.002, 0, 005 or 0.1).
14.2 Dynamic case
To examine the estimation procedure for the dynamic case described in Section 11, we can simulate
measurements of the labeled Lgr, unlabeled Ugr and total fraction Tgr for a given number of genes
g ∈ G and replicates r ∈ R. By applying the formulae from Section 12 we can yield the values for
Agr, Bgr and Cgr and subsequently adopt the procedure given in Section 14.1 to finally derive Lgr,
Ugr and Tgr. To improve over the fact that Equations (79) and (80) are subject to a long run time
due to double integrals that need to be solved numerically, we propose the following restriction: The
decay rate λg is assumed to be piecewise constant (Figure 32), i.e.
λg(t) = λg,i hg,i−1 ≤ t < hg,i, i = 0, ..., n hg,0 = 0, hg,n =∞, hg,i ∈ N+0 , λg,i ∈ R
+.
(121)
Its integral can hence be written as sum
Θ∗g(t) :=
ˆ t
0
λg(ξ)dξ =
∑
{i | t≤hg,i}
(λg ·min(t , hg,i)− hg,i−1) , (122)
see Figures 32 and 33.
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Figure 32: Plot shows an example of a piecewise constant decay rate. The striped area under the curve
gives the value of its antiderivative at timepoint 45.
Figure 33: Plot shows the antiderivative of the decay rate function given in Figure 32. The resulting
function can be expressed piecewise linear.
We set
Θg(t, t0) :=
ˆ t
t0
λg(ξ)dξ =
ˆ t
0
λg(ξ)dξ −
ˆ t0
0
λg(ξ)dξ = Θ
∗
g(t)−Θ∗g(t0) (123)
and in this way
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Cgr(t) = e
−Θg(t,0)
[
Cgr(0) +
ˆ t
0
Nr(0)µg(ξ)e
αξ+Θg(ξ,0)dξ
]
. (124)
We also set
Bgr(t, t0) = Cgr(t0)e
−Θg(t,t0) (125)
with
Bgr(t0) = Cgr(t0) (126)
and hence
Agr(t, t0) = Cgr(t)−Bgr(t, t0). (127)
We further assume the synthesis rate µg to be a piecewise constant function
µg(t) = µg,i hg,i−1 ≤ t < hg,i, µg,i ∈ R+. (128)
Note: We can always achieve that the synthesis rate µg,i and the decay rate λg,i have identical
breakpoints (hg,i)i=0,...,n by refining the respective intervals.
As a consequence, Equation (124) can be formulated as
Cgr(t) = e
−Θg(t,0)
[
Cgr(0) +Nr(0)
∑
i
φ(min(t, hg,i−1) , min(t, hg,i))
]
(129)
with
Cgr(0) =
µg,0
λg,0 + α
(130)
and
φ(hg,i−1, hg,i) =
ˆ hg,i
hg,i−1
µg,ie
αξ+Θg(ξ,0)dξ. (131)
Equation (131) can also be formulated as
φ(hg,i−1, hg,i) =
ˆ hg,i
hg,i−1
µg,ie
αξ+λg,i·(ξ−hg,i−1)+Θg(hg,i−1,0)dξ (132)
and be solved as
φ(hg,i−1, hg,i) =
[
µg,ie
αξ+λg,i·(ξ−hg,i−1)+Θg(hg,i−1,0)
α+ λg,i
]hg,i
hg,i−1
(133)
So we finally get
φ(hg,i−1, hg,i) =
µg,ie
Θg(hg,i−1,0)
[
eαhg,i+λg,i·(hg,i−hg,i−1) − eαhg,i−1
]
α+ λg,i
(134)
We simulated profiles for 5000 genes g in the following way: The initial synthesis rate and decay
rate distributions are drawn randomly from F distributions.
t1/2g ∼iid F(15, 15) · 12 (135)
to yield
λinitialg = log(2)/t1/2g (136)
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and
µinitialg ∼
iid
F(5, 5) · 18. (137)
We further set
shockg ∼
iid
1/max(ηg, 1) , ηg ∼
iid
N (8, 4) (138)
and
inductiong ∼
iid
max(ιg, 1) , ιg ∼
iid
N (8, 4). (139)
For the synthesis rate we set
µg(t) =

µinitialg t < 12
µinitialg · shockg 12 ≤ t < 18
µinitialg · shockg · inductiong t ≥ 18
(140)
and for the decay rate
λg(t) =

λinitialg t < 12
λinitialg · shockg 12 ≤ t < 18
λinitialg · shockg · inductiong 18 ≤ t < 2
λinitialg t ≥ 27
(141)
Figure 34: Each plot corresponds to one timepoint. Log2(decay rate fold λg,i/λg,1) for i = 2, ... , 6 versus
log2(synthesis rate fold µg,i/µg,1) for i = 2, ... , 6 for the last timepoint compared to the first timepoint.
Each point corresponds to one gene, which is colored according to its affiliation with one of 5 clusters defined
in a normalization-independent manner [170]. Ellipses show the 75% regions of highest density within each
cluster, assuming Gaussian distributions. The shape of the ellipses indicates the correlation structure within
a cluster.
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As a result, Equations (140) and (141) give a time course of 36 minutes in total (Figure 34). The
labeling durations were each set to 6 minutes. We then applied our estimation procedure (Section
11) to fit the parameters arcr ,
br
cr
, brar , pr, λgr, t1/2gr and µgr see (Figure 35).
Figure 35: Comparison between true (= simulated) and estimated parameters in an absolute manner and
on the basis of their ranks: synthesis rate µg, decay rate λg and half-life t1/2g of the time window 18−24. The
rightmost plots shows the log-ratio of the estimated vs. the true parameters in a histogram. The mode is the
maximum of the corresponding density indicated by the blue line. As a measure for a systematic deviation
from zero (depicted in green) we calculated the mean relative deviation (MRD). The MRD is defined by
mean
(
|τestg −τ
true
g |
τtrueg
)
with τ = µ, λ or t1/2.
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Part III
Results & Discussion
15 DTA measures rates of mRNA synthesis and decay in S.cerevisiae
Cellular growth and stress response require gene regulation at the level of mRNA transcription and
stability. To study gene regulation in a eukaryotic cell, the rates of mRNA synthesis and decay
must be measured without perturbation of the cellular system, and changes in these rates must be
monitored to follow a cellular response. This cannot be achieved by standard transcriptomics, which
only measures mRNA abundance. The yeast Saccharomyces cerevisiae is an ideal model eukaryote
for systemic analysis, but mRNA synthesis and decay rates can currently not be measured without
cellular perturbation. Synthesis rates can be measured by nuclear run on [67], but this requires
sarkosyl treatment that inhibits cellular processes. Decay rates can be measured after blocking
transcription with inhibitors (Section 3.2) [77, 18, 78, 162, 174, 215, 7, 143] but this is inherently
cell invasive. In addition, decay rates can be measured with a temperature-sensitive yeast strain
(Section 3.1) [90, 205, 77, 176], but this requires a perturbing heat shock.
Unperturbed RNA synthesis and decay rates can be obtained via metabolic RNA labeling and kinetic
modeling (Section 4) [36, 102, 52, 64, 137]. The nucleoside analog 4-thiouridine (4sU) is taken up
by eukaryotic cells and incorporated into mRNA during Pol II transcription (Section 4.1) [133].
The thiol-labeled newly transcribed RNA can then be isolated by affinity chromatography [102] or
by biotinylation and purification with streptavidin-coated magnetic beads [36, 52]. Although this
approach is generally applicable to mammalian, insect, and plant cells, RNA labeling is not directly
applicable to yeast.
In this study, we report on the development of an easy-to-use, non-perturbing method to measure
mRNA synthesis and decay rates in yeast, referred to as DTA (Section (4.2)). Thereby, changes
in synthesis and decay rates can be monitored in yeast at unprecedented sensitivity and temporal
resolution. This is exemplified by analysis of the osmotic stress response, a conserved stress response
pathway and one of the best studied gene-regulatory systems in yeast [89, 48].
Osmotic stress response is induced in yeast upon exposure to high concentrations of salt. The stress
response involves activation of the conserved MAP kinase Hog1, which induces an altered activity
of ion membrane transporters [157], cell cycle arrest [56], dissociation of many chromatin-bound
proteins [157], translation inhibition [196], and reprogramming of transcription [124]. The osmotic
stress response was analyzed globally by transcriptomics [70, 33, 132, 124], run-on analysis [166],
and transcription inhibition [139]. These studies revealed changes in mRNA synthesis and decay and
suggested three phases of the stress response, referred to as shock, induction, and recovery phase.
We report that DTA recaptures many known features of the stress response, but that it also provides
new insights and uncovers misleading drawbacks of traditional methods. DTA reveals new salt stress
genes, and a temporary interdependence of mRNA synthesis and decay. The results are validated
by genomic occupancy profiling of Pol II before and after stress. This confirmed that redistribution
of Pol II over the genome predicts global changes in mRNA synthesis rates. These results establish
DTA as a highly valuable tool for the analysis of dynamic changes in mRNA metabolism and as a
method that can provide quantitative data for modeling complex gene-regulatory systems.
15.1 Non-perturbing RNA labeling in yeast
The nucleoside analog 4sU is readily taken up by cells of a broad range of eukaryotic organisms and
is efficiently incorporated into their newly transcribed RNA (Section (4.1)). This can be used to
metabolically label and isolate newly transcribed RNA from total cellular RNA with high specificity
[102, 52]. To establish 4sU labeling in the budding yeast S.cerevisiae, we cultured cells in the presence
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of 100µM−5mM 4sU. Although we observed concentration dependent, specific incorporation of 4sU,
the efficiency of incorporation was low and the amount of recovered newly transcribed RNA was
very small (not shown). This hinted at inefficient uptake of 4sU into yeast cells rather than an
intracellular block in activation or incorporation by RNA polymerases.
In the fission yeast Schizosaccharomyces pombe, expression of the human equilibriative nucleoside
transporter (hENT1) enables cellular uptake of the nucleoside analog 5-bromo-2’-deoxyuridine, re-
sulting in labeling of DNA during replication [88]. To test whether this transporter could also
mediate efficient uptake of 4sU in the budding yeast S.cerevisiae, and thus install efficient RNA
labeling, we grew a BY4741 strain expressing hENT1 up to a logarithmic phase, added 4sU, and
isolated RNA at several time points (Figure 7, Section 19.1). This significantly enhanced 4sU in-
corporation to a level similar to that generally achieved in mammalian cells, thereby facilitating
efficient separation of total cellular RNA into newly transcribed and pre-existing RNA.
We next tested whether Pol II incorporates the thionucleotide normally into RNA in vitro [25,
189]. Pol II used the substrates UTP and 4sU-triposphate (4sUTP) with very similar kinetics
(Supplementary Figure S1 [136]). Whereas kcat was unchanged, KM increased from 3 nM for UTP to
13 nM for 4sUTP, indicating a slightly decreased substrate affinity that may result from weaker base
pairing between 4sUTP and the template (Figure 6). This minor difference is likely irrelevant in vivo,
where substrate concentration is higher by several orders of magnitude than these KM values. To
investigate whether RNA labeling perturbed gene expression in vivo, we compared RNA levels in 4sU-
treated hENT1-expressing cells with untreated wild-type cells (Section 19.1). For a labeling period
of 6 min, there were no significant changes in RNA levels as measured with Affymetrix expression
arrays (Figure 36, Supplementary Section 12.6, Supplementary Table 4, Supplementary Figures
S11, S12 [136]). Thus, RNA labeling perturbs neither transcription nor the yeast transcriptome.
Although other cellular processes may be influenced by 4sU, their effect on mRNA metabolism is
apparently not significant, as changes in the total mRNA levels were not observed.
Figure 36: The yeast transcriptome is undisturbed by expression of the human nucleoside transporter
hENT1. The volcano plot compares mRNA levels after 6 min labeling versus wild-type cells without labeling.
Each dot corresponds to one gene, the x axis displays the log2(fold) of that gene, the y axis represents the
multiple testing adjusted P-value (see Section 18.3). In all, 17 genes showed a significant change in mRNA
levels (adjusted P-value 5%), only three of which were at least twofold. The results for the other tested
labeling periods are given in the Supplementary Section 12.6.[136]
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15.2 Dynamic transcriptome analysis
To determine the optimum labeling time, we purified total, newly transcribed (labeled), and pre-
existing (unlabeled) RNA at 3, 6, 12, and 24 min after 4sU addition, and subjected these fractions to
expression array analysis (Section 19.1). Replicate data always showed correlations above 0.9 for each
RNA fraction at each time point (Supplementary Figure S2 [136]). To estimate mRNA synthesis and
decay rates from individual time point measurements, we developed a new quantitative steady-state
model (Section II).
Reproducibility assessment of the data (Supplementary Section 12.6 [136]) and simulation stud-
ies (Supplementary Section 13.4 [136]) suggested an optimum labeling time of 6 min, which was
subsequently used in all experiments. This was short enough to meet the assumption of constant
synthesis and decay rates during labeling, but sufficiently long to yield enough labeled RNA for
robust measurements. The relative decay rates within an experiment can be estimated reliably, but
the absolute values are more difficult to obtain (Supplementary Section 13.5 [136], Section 18.4). To
investigate this, we conducted a classical decay time course experiment using transcription inhibition
and RT–PCR, and obtained generally consistent decay rates (Supplementary Figure S3 [136]).
Figure 37: (A) Scatter plot of the mRNA half-lives t1/2g and synthesis rates µg for exponentially growing
yeast cells. Colored points belong to the indicated gene sets (green, ribosomal biogenesis genes; violet, riboso-
mal protein genes; red, stress genes; dark gray, transcription factors (TFs). Assuming Gaussian distributions,
ellipses show the 75% regions of highest density for the respective sets. Overall half-lives and synthesis rates
are uncorrelated (Spearman correlation 0.06), however some gene groups behave differently (correlations:
Ribosomal protein genes (Rp) 0.79, Ribosomal biogenesis genes (RiBi) 0.35, ISA stress module genes 0, TFs
0.07). (B) Gene Ontology (GO) analysis of the short-lived mRNAs (lower 25% of the half-life distribution).
The 10 most significant categories are displayed, sorted from bottom (most significant) to top (Materials and
methods). Red line, proportion of short-lived transcripts in the whole population (25% by construction).
The number of short-lived transcripts in the resp. GO category is given relative to the GO category size
(green bar) and relative to the number of short-lived transcripts (black line). Dashed line, relative size of the
GO set in the whole population. (C) Gene Ontology (GO) analysis of the long-lived mRNAs (upper 25% of
the half-life distribution), analogous to (B)
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15.3 Synthesis rates are low for most mRNAs
We used DTA to derive synthesis rates and decay rates (half-lives) for most (4508) of the yeast
mRNAs (Section II). On the basis of a published rough estimate of 15000 mRNA transcripts per
yeast cell [87], we calculated the synthesis rate as the number of mRNA molecules produced per cell
per cell cycle time (150 min) (Figure 37). The obtained rates correlated with previously reported
rates obtained by nuclear run-on [155] (Supplementary Figure S4 [136]). Synthesis rates ranged
from 1 to ∼ 600 mRNAs per cell per cell cycle time. The synthesis rate distribution is strongly
right skewed (skewness 5), with a median synthesis rate of 18 RNAs per cell and cell cycle time
(mean 31, 1st quartile 11, and 3rd quartile 33). This shows that only a few copies are made for
most mRNAs (Figure 37A). This observation is generally consistent with single molecule live-cell
imaging [151]. We observed that mRNAs with high synthesis rates encoded ribosomal protein genes
and genes involved in ribosome biogenesis, whereas mRNAs with low synthesis rates stemmed from
genes that are silenced during normal growth, including most TFs (Figure 37).
15.4 mRNA decay is not correlated with synthesis
DTA measured a median mRNA half-life of 11 min (mean 14, 1st quartile 9, and 3rd quartile
17 min, Figure 37). The half-life distribution is strongly right skewed (skewness 8). Thus, most
mRNAs in yeast are synthesized and degraded several times during a cell cycle time. Gene ontology
(GO) analysis revealed that mRNAs with the shortest half-lives are involved in the regulation of
transcription and the cell cycle, and mRNA processing (Figure 37B). In contrast, mRNAs with long
half-lives are involved in carbon and nitrogen metabolism and include many transcripts encoding
housekeeping enzymes (Figure 37C). The decay rates did not correlate with published rates [90,
205, 77, 176, 53] (see also Section 16.3), which were obtained with protocols that perturb mRNA
metabolism (Section 3). The decay rates did not correlate with mRNA length (Supplementary
Figure S6 [136]), inconsistent with models that assume stochastic degradation, but consistent with
degradation control at the level of mRNA deadenylation and decapping. Many mRNAs with long
half-lives contained AU-rich elements in their 3’-untranslated region, consistent with a stabilizing
role of these elements [11]. Decay rates correlated weakly with mRNA levels (Spearman correlation
0.59), but synthesis rates correlated well with mRNA levels (Spearman correlation 0.84). However,
decay rates did not correlate with synthesis rates (Spearman correlation 0.15). This indicates that
mRNA decay and synthesis are functionally independent during normal growth, and that both
processes contribute to setting cellular mRNA levels.
15.5 DTA monitors rate changes during osmotic stress
The above analysis and published studies estimate mRNA synthesis and decay rates only in the
steady state [52, 6]. To monitor rate changes, and thus the dynamics in mRNA metabolism, we
extended DTA to a time-resolved analysis of the osmotic stress response (Section II). Cells were
grown up to a logarithmic phase and split into control and sample cultures (Figure 38A). Sodium
chloride was added to the sample culture and made up to a concentration of 0.8 M. Control and
sample cultures were divided in aliquots, and 4sU was added at 0, 6, 12, 18, 24, and 30 min after
salt addition. After labeling for 6 min, total, labeled, and unlabeled RNA was purified and analyzed
with gene expression arrays. The rates were estimated using DTA within the time windows 0 − 6,
6− 12, 12− 18, 18− 24, 24− 30, and 30− 36 min after stress induction. The results were confirmed
for selected genes by quantitative RT–PCR at 12, 30 and 36 min after salt stress, wherein strong
rate changes were observed (Supplementary Figure S3 [136]).
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Figure 38: (A) Design of the time series experiment. Each time window corresponds to one sample, left
end marks the start of the 4sU labeling, right end marks the time of mRNA extraction. Upper panel shows
the drop in labeling efficiency from roughly one 4sU in 200 uracils to one 4sU in 400 uracils during the
osmotic stress response. (B) Increased sensitivity and temporal resolution of DTA compared with standard
transcriptomics. Gray, time course of the total mRNA fraction of the Hog1-induced genes [32]. Red, time
course of the synthesis rates of the same gene set. The solid lines represent the time course of the median,
the shaded bands are the central 95% regions. In contrast to the monotonically increasing total mRNA time
course, the synthesis rates clearly show three response phases. (C) Expression changes of the five clusters (up,
up-even, even, down-even, down see Materials and methods) that were defined in a normalization-independent
manner. The box plot shows synthesis rate folds (30 versus 0 min).
15.6 Three phases of the osmotic stress response
DTA resolved the three phases of the osmotic stress response with unprecedented clarity. In the
first 12 min after salt addition (shock phase), essentially all synthesis and decay rates decreased,
reflecting global transcription down-regulation and mRNA stabilization. Within 12 − 24 min after
salt addition (induction phase), synthesis rates strongly increased for a subset of mRNAs. These
stress-induced mRNAs show increased decay rates, likely to ensure their rapid removal toward the
end of the response. Finally, decay rates were mostly restored, whereas a fraction of the synthesis
rates remained at levels distinct from the starting values (recovery phase). We could not monitor
complete recovery, which takes about 2 h [124], but a fraction of synthesis rates apparently remains
at values different from the starting values, to ensure continued expression of salt homeostasis genes,
and lower expression of housekeeping genes. DTA also revealed a drop of labeling efficiency from
0.5% (1 4sU in ∼ 200 nucleotides) to 0.27% (Figure 38A), reflecting the known inhibition of cellular
uptake of small molecules during stress.
15.7 Temporary correlation of mRNA synthesis and decay rates
We transformed all rates to their ranks within the rate distributions, to circumvent an error-prone
estimation of an unknown normalization factor between measurements at different time points. By
comparing the ranks of synthesis rates in the datasets, 6 and 36 min after salt addition, five clusters
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of genes were defined (Figure 38C): ‘up’ (217 genes, rank gain > 2000),‘up-even’ (456 genes, rank
gain 1000 − 2000), ‘down-even’ (498 genes, rank loss 1000 − 2000), ‘down’ (401 genes, rank loss
> 2000), and ‘even’ (all remaining 2936 genes). Although global mRNA synthesis and decay were
not correlated before stress, some gene groups showed positive and negative correlations during
stress (Figure 37). An analysis of the changes in synthesis and decay rates reveals a temporary
interdependence of the rate changes of mRNA synthesis and decay during the first two stress phases
(Figure 39, Supplementary movie [136]). During the shock phase, a decrease in synthesis rate
generally goes along with a decrease in decay rate. During the induction phase, an increase in
synthesis rates generally goes along with an increase in decay rate. They again become uncorrelated
during recovery. The nature of a possible physical coupling underlying this temporary correlation
of rates remains to be explored.
Figure 39: Dynamics of synthesis and decay rates in the osmotic stress time series. Each plot corresponds
to one timepoint. Log2(decay rate fold λg,i/λg,1) for i = 2, ... , 7 versus log2(synthesis rate fold µg,i/µg,1) for
i = 2, ... , 7 for the last timepoint compared to the first timepoint. Each point corresponds to one gene, which
is colored according to its affiliation with one of the clusters in Figure 38. Ellipses show the 75% regions of
highest density within each cluster, assuming Gaussian distributions. The shape of the ellipses indicates the
correlation structure within a cluster.
15.8 High temporal resolution reveals mRNA dynamics
Resolution of the three phases of stress response depended on DTA and was not possible by measuring
total mRNA levels alone (Figure 38B). To test the performance of DTA with an unbiased gene set,
we monitored the previously described 305 Hog1-responsive genes [32]. DTA detected an initial
decrease in synthesis rates during shock, whereas total RNA levels increased (Figure 38B). This
was, however, not due to increased transcriptional activity, but rather due to residual transcription
activity combined with mRNA stabilization (Figure 39). Also, the signal-to-noise ratio in detection
of changes in synthesis rates was on average two times higher than that of measuring differences
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in total mRNA levels (Supplementary Figure S7 [136]). Thus conventional transcriptomics fails to
unveil the nature of the changes in mRNA metabolism upon stress, which are however monitored
by DTA.
15.9 High sensitivity reveals new stress response genes
Owing to the increased sensitivity, DTA reveals many genes that are induced during stress. The up
cluster contained genes associated with GO terms related to stress response. Of the stress module
genes as defined by the Iterative Structure Algorithm [97], 74% showed a rank gain greater than
1000. The up cluster contained only three TFs, consistent with the pre-existence of TFs for stress
response and their post-transcriptional activation ([157], and references therein). The up cluster
contained 62% of the genes that were considered significantly up-regulated by a factor of at least
two in a recent study of the osmotic stress response [32]. However, DTA also detected 58 new genes
involved in the osmotic stress response (Supplementary Figure S8 [136]). These are mostly genes
of unknown function, except Ubc5, which is known to mediate degradation of abnormal proteins
during cellular stress. Of genes in the up cluster, 35% were uncharacterized, compared with only
16% over all yeast genes. Yeast strains with single knockouts of the newly revealed stress genes did
not generally show growth defects under high salt conditions (Supplements, Part IV [136]), providing
a possible explanation for why they were not discovered previously.
Figure 40: Pol II gene occupancy predicts mRNA synthesis. The vectors of mean Pol II occupancies on
transcribed regions were calculated from ChIP-chip data at 0, 12, and 24 min after salt stress and compared
with the vectors of total mRNA levels (left), labeled mRNA (middle), and synthesis rates (right) at each
time point of the osmotic stress time course experiment. The pair-wise Spearman correlation values are
represented by color-coded squares.
15.10 Genomic Pol II redistribution predicts mRNA synthesis rate changes
To investigate whether mRNA synthesis rates correlate with the presence of Pol II at transcribed
genes, we determined occupancy profiles for the Pol II subunit Rpb3 by chromatin immunopre-
cipitation (ChIP) and tiling microarray (chip) analysis, and calculated the mean Pol II occupancy
between the transcription start site (TSS) and the polyadenylation site (pA) for each gene [129]. We
also measured ChIP-chip profiles 12 and 24 min after salt addition, to investigate whether Pol II is
redistributed over the genome upon stress. At all three time points (0, 12, and 24 min), the mean
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Figure 41: Dynamics of the mean Pol II occupancy profiles of all selected clusters (Figure 38, Supplementary
Section 17 [136]). Only genes of at least 1000 base pairs (bps) are considered. Left: Profiles are taken after
0, 12, and 24 min of osmotic stress (light blue, blue, and dark blue lines). Vertical dotted lines are drawn at
the transcription start site (TSS) and the polyadenylation site (pA) site. The plot shows the ±500 bp regions
around the TSS and the pA sites, together with the intermediate part, which has been rescaled to a length
of 400 (Supplementary Section 16 [136]). Right: Heatmaps of the Pol II profiles for all cluster at 0, 12, and
24 min. Each row corresponds to one gene. The vertical dotted lines mark TSS and pA of each gene. Pol II
occupancy from low to high is coded with colors ranging from dark to bright.
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Pol II gene occupancy was calculated. The three resulting Pol II occupancy vectors were compared
with the vectors of total RNA, newly synthesized RNA, and synthesis rates at all six 6-min time
windows of the osmotic stress (Figure 40).
Pol II gene occupancies at 0, 12 and 24 min correlated only weakly with mRNA levels, but very well
with the levels of labeled mRNA and with the synthesis rates at the corresponding time points (Figure
40). The results also demonstrated the inferior temporal resolution of standard transcriptomics, as
Pol II occupancy 12 and 24 min after stress induction correlated with mRNA levels at a later time
point (Figure 40).We averaged Pol II occupancy profiles over genes belonging to the even, down, and
up clusters (Figure 41). The even cluster showed a typical gene-averaged profile with elevated Pol II
levels on the transcribed region and peaks around the TSS and pA site. This profile persisted during
stress, although overall polymerase levels decreased. The down cluster genes apparently lost most if
not all Pol II during stress. In contrast, the up cluster genes did not contain detectable amounts of
Pol II before stress but gained Pol II during stress. The shape of the averaged profile of up cluster
genes after 24 min of salt stress showed an even distribution of Pol II that was very different from
the canonical profile (Figure 41), maybe because of a high density of Pol II on these stress-induced
genes. Thus, Pol II occupancy predicted mRNA synthesis rates and Pol II redistribution upon stress
predicted changes in synthesis rates. On the other hand, the observed correlations confirm that DTA
realistically monitors changing transcriptional activity.
15.11 Summary & Outlook
In this study, we develop DTA as a tool for measuring mRNA synthesis and decay rates in yeast
on a global scale and in a dynamic manner without system perturbation. DTA involves genetically
facilitated cellular uptake of the nucleoside analog 4sU, metabolic RNA labeling, separation and
microarray analysis of three different RNA fractions (total, newly transcribed, and pre-existing
RNA). A quantitative dynamic model then enables extraction of synthesis and decay rates from the
array data. As we select for polyadenylated RNA in the protocol, and the probes on the array are
predominantly located in the 3’ region of transcripts, only complete transcripts are detected and
the obtained synthesis rates reflect the production of complete mRNAs. The application of DTA to
growing yeast cells revealed that most genes produce only a few copies of mRNA per cell per cell
cycle time, and that transcript turnover is generally rapid, with a median mRNA half-life of 11 min,
as well as that synthesis and decay are generally not correlated.
DTA was used to follow dynamic changes in mRNA synthesis and decay rates, as exemplified by the
osmotic stress response. This showed that DTA has higher sensitivity and temporal resolution than
ordinary transcriptomics, and thus provides new biological insights. DTA identified 58 new genes
induced by osmotic stress, including many genes of unknown function. DTA also revealed a correlated
alteration of mRNA synthesis and decay during the first two phases of the stress response. In the
initial shock phase, transcription is globally slowed down and mRNAs are stabilized, apparently
to store them. During the subsequent induction phase, synthesis rates for a subset of mRNAs are
strongly increased, and the resulting mRNAs are destabilized, thus allowing for their rapid removal
after stress. During recovery, decay rates are restored whereas synthesis rates may remain at altered
values.
More generally, altered gene expression programs resulting from cellular adaptation may involve
persistently altered mRNA synthesis rates, whereas mRNA decay rates may be similar for different
programs. Indeed, theoretical considerations show that changes in synthesis rate can more quickly
change mRNA levels for transcripts with low abundance, which dominate in the cell [3]. Changes
in decay rate can only efficiently change mRNA levels for highly abundant transcripts (Section 12).
This concept is realized in the osmotic stress response, and likely in other gene regulatory systems.
Many of our observations are consistent with published data on the osmotic stress response. Ge-
nomic run-on analysis showed that osmotic stress provokes mRNA stabilization and sequestration
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into P-bodies [166]. P-bodies develop at 0.8 M NaCl within minutes [191]. Global transcription inhi-
bition showed that repressed mRNAs are stabilized, whereas induced mRNAs are destabilized [139].
The rapid decrease of mRNA synthesis and decay rates during the shock phase is pre-transcriptional
as suggested [157, 134]. This may go along with a transient depression of translationally active ribo-
somes [206]. Part of the shock response may stem from changing the post-translational modification
of pre-existing proteins, as 15% of protein phosphorylation sites change within 5 min after stress
[183]. Only during the induction phase, an increase in abundance of a subset of proteins occurs that
correlates with an increase in mRNA levels (Supplementary Figure S27 [136]). A correlated response
of mRNA levels and the translatome is also revealed by global analysis of ribosome associated mR-
NAs [80]. In the future, insights from DTA and Pol II profiling may be used to improve models of
the osmotic stress response [32, 142].
The mRNA synthesis rates obtained by DTA are robust and realistic, as they correlate with Pol
II occupancy of transcribed regions, as measured here by ChIP-chip profiling. DTA and Pol II
ChIP-chip apparently monitor the same biological process, transcriptional activity, in contrast to
conventional transcriptomics, which monitors mRNA levels. Thus, previously obtained correlations
of Pol II occupancy with mRNA levels [8, 185, 154, 201, 129, 165] are only an indirect effect of
the correlation of mRNA synthesis rates with mRNA levels as reported here. DTA-derived rates of
mRNA synthesis are averaged over a cell population and a time period of 6 min, suggesting that
they are independent of the nature of transcription, which may occur in bursts and discontinuously.
DTA has a great potential for studying gene regulatory systems and mRNA metabolism. It may
be used to characterize gene expression programs under defined conditions, and to analyze the
influence of changes in environmental conditions or the effect of small molecules on mRNA turnover.
It may also be used to study the global mechanisms of gene regulation by introducing mutations
that interfere with particular aspects of transcription and its regulation. DTA may further be used
to decipher the pathways of mRNA decay and the global regulation of mRNA half-lives by RNA-
binding proteins. Such studies however require genetic perturbation and, therefore, new tools for the
normalization of rates extracted from array measurements with mutant and wild-type yeast strains.
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16 cDTA reveals mutual feedback between mRNA synthesis and
degradation
Cellular gene expression is controlled by mRNA levels, which are governed by the rates of nuclear
mRNA synthesis and cytoplasmic mRNA degradation. The rates of mRNA synthesis are regulated
during RNA polymerase (Pol) II transcription in the nucleus (Section 1.1), whereas bulk mRNA
degradation occurs in the cytoplasm (Section 1.2). During transcription, the mRNA receives a 5’-
cap and a 3’-poly(A) tail. The mature mRNA is then exported to the cytoplasm, translated, and
eventually degraded co-translationally [93]. Cytoplasmic mRNA degradation generally begins with
shortening of the poly(A) tail by the Ccr4-Not complex that contains the deadenylases Ccr4 and
Pop2 (also known as Caf1) [119, 195]. The mRNA is then decapped and degraded by exonucleases
from both ends. Despite the spatial separation of mRNA synthesis and translation/degradation,
there is evidence that these processes are coordinated [122, 123, 82].
To investigate coordinated RNA synthesis and degradation, absolute changes in synthesis and decay
rates must be measured after introducing a genetic perturbation that impairs either synthesis or
degradation. Rates of mRNA synthesis and degradation can be measured by Dynamic Transcriptome
Analysis (DTA) in yeast (Section 15). Newly synthesized RNA is labeled with 4-thiouridine (4sU),
which is taken up by cells that express a nucleoside transporter. After 6 minutes of labeling,
total RNA is extracted and separated into newly synthesized (labeled) and pre-existing (unlabeled)
fractions. Total, labeled, and unlabeled fractions are analyzed with microarrays and the data are
fitted with a dynamic kinetic model to extract synthesis and decay rates (Section II). Whereas
DTA accurately measures the relative rates for different RNAs within a single sample, it cannot
compare rates from different samples, since the samples differ by an unknown global factor (Section
18.4). In standard transcriptomics, comparison between samples with different mRNA levels may
be achieved by counting cells and spiking RNA standards into the samples [90, 205, 198]. However,
such normalization does not take into account differences in cell lysis and RNA extraction efficiency,
which can vary so strongly that no conclusions are possible.
To enable normalization between DTA measurements of different samples, we extended DTA to com-
parative DTA (cDTA, Section 4.3). In cDTA, a defined number of labeled fission yeast Schizosac-
charomyces pombe (Sp) cells is added to the budding yeast Saccharomyces cerevisiae (Sc) sample
before cell lysis and RNA preparation, and is used as an internal standard. Thereby, cDTA allows
the absolute quantification and accurate comparison of mRNA synthesis and decay rates between
samples. cDTA is a novel method that monitors absolute changes in eukaryotic mRNA metabolism
upon genetic perturbation. We applied cDTA to Sc cells that are impaired in either mRNA synthe-
sis or degradation. This revealed compensatory changes in degradation and synthesis, respectively,
which indicates that a eukaryote can buffer mRNA levels to render gene expression robust. After
our work was completed, an independent study appeared that postulates a similar compensation on
an evolutionary scale [53].
16.1 Comparative Dynamic Transcriptome Analysis (cDTA)
To measure changes in mRNA synthesis and decay rates between different strains of budding yeast
(Sc), we included the distantly related fission yeast (Sp) in our DTA protocol as an internal standard
(Figure 8, Section 4.3). We counted Sc sample cells and Sp control cells and mixed them in a
defined ratio (Section 20.2). The resulting cell mixture was lysed, total mRNA extracted, labeled
RNA purified, and microarrays were hybridized as described in Section 19.1. The RNA mixture
was quantified on a microarray that contains probes for both Sc and Sp transcripts (Affymetrix®
GeneChip® Yeast Genome 2.0 Array) [136]. We used 4-thiouracil (4tU) instead of 4sU for Sc RNA
labeling, because it is taken up by Sc [141] without expression of a nucleoside transporter [136]. 4tU
labeling did not affect normal cell physiology (Supplementary Figures S1 [187]) and allowed growth
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of yeast in YPD instead of selective medium. We quantified only labeled and total RNA, because
the unlabeled fraction was not required for rate extraction.
Figure 42: (A) Assessment of cross-hybridization. Scatterplot of log intensities of 10, 928 Affymetrix probe
sets. The values on the x- resp. y-axis are obtained as the mean of two pure Sc resp. Sp replicate samples
that were hybridized to the arrays. Sc and Sp probe sets (heat-colored and grey-scaled, respectively) can be
separated almost perfectly. 23 out of 5, 771 Sc probe sets show intensities above a (log) background intensity
threshold of 4.5 in the Sp sample, whereas 8 out of 5, 028 Sp probe sets were above background in the Sc
sample. These 31 probe sets are regarded as affected by cross-hybridization (green circles). Of these, 16 probe
sets were excluded from analysis because all probes were affected by cross-hybridization (Methods [187]).
(B) Linear measurement range. Exemplary illustration showing that the relation of mRNA concentration
(real amount) and mRNA intensity (fluorescent scanner readout) follows the Langmuir adsorption model
[84, 85, 86, 180]. The green line indicates linearity. The black line shows sigmoidal behavior, resulting from
noise at low hybridization levels and saturation effects at high hybridization levels. The grey stripe indicates
the linear measurement range that we defined as an intensity range of 4.5 − 8 (natural log basis) based on
noise signals below 4.5, for example for probes that detect transcripts of genes that were knocked out, and
based on observed saturation effects above 8. (C) Calibration of Sc:Sp cell mixture ratio. The optimal cell
mixture ratio has been chosen to maximize the number of probes for both Sc and Sp that fall into the linear
measurement range (B). Sc and Sp cells were mixed in Sc:Sp ratios of 1:1, 3:1, and 10:1. The respective
median mRNA level ratios are 0.3, 0.95, and 3.02. Log(RNA intensity) distributions of Sc (red) and Sp
(grey) are shown. The median intensity level of Sp is approximately three times higher than that of Sc. As a
consequence, a Sc:Sp cell mixture ratio of 3:1 was used. (D) Comparison of the three different cell mixtures
of (C) in pairwise log-log scatter plots. All arrays are normalized to a common median of 4, 052 Sp probe
sets (grey-scaled). 4, 475 Sc probe sets (those in the linear measurement range) are shown in heat colors.
The parallel offset of the Sc probe sets from the main diagonal measures the mRNA level differences of Sc
in the three cell mixtures. The differences should be 3.3, 10, and 3 when we plot Sc:Sp ratios of 10:1 vs. 3:1,
10:1 vs. 1:1, and 3:1 vs. 1:1, respectively. The corresponding measured offsets are 3.14, 9.46, and 3.01, and
thus in very good agreement.
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We first tested whether the Sc sample showed cross-hybridization to Sp array probes and vice versa.
When either a Sc or Sp sample was hybridized to the array, cross-hybridization occurred for a minor
fraction of the probes (Section 20.3) when a conservative intensity cut-off of 4.5 (log(intensity) values
after pre-processing) was used (Figure 42A). Cross-hybridizing probes were excluded from further
analysis, leading to loss of only 16 out of 10, 799 probe sets (Section 20.3). The mixing ratio of Sc:Sp
cells was tuned to 3:1, to maximize the overlap of the Sc and Sp expression intensity distributions
(Figure 42B). This ensures that after calibration most Sc and Sp probe intensities are in the linear
measurement range of the microarray, an important prerequisite for our calculations. We restricted
our analysis to RNAs with log(intensity) signals above 4.5 and below 8 (Figure 42B).
Figure 43: Comparison of the three different cell mixtures of Figure 42 in pairwise log-log scatter plots. All
arrays are normalized to a common median of 4, 052 Sp probe sets (grey-scaled). 4, 475 Sc probe sets (those
in the linear measurement range) are shown in heat colors. The parallel offset of the Sc probe sets from the
main diagonal measures the mRNA level differences of Sc in the three cell mixtures. The differences should
be 3.3, 10, and 3 when we plot Sc:Sp ratios of 10:1 vs. 3:1, 10:1 vs. 1:1, and 3:1 vs. 1:1, respectively. The
corresponding measured offsets are 3.14, 9.46, and 3.01, and thus in very good agreement.
16.2 Rate extraction from cDTA data
To obtain absolute synthesis and decay rates for Sc and Sp, we derived the ratios of labeled to
total RNA intensities cSc and cSp for Sc and Sp, respectively. These ratios set the global median
level of synthesis and decay rates and rely on a robust previous estimate of the median Sc half-life
[136] for which labeled, total, and unlabeled RNA fractions were available. Once cSp is known, the
measured levels of the Sp standard can be used to calibrate the Sc data (Figure 44A). This new
normalization method allows rate estimation from labeled and total quantities alone (Section 20.3).
Our published median half-life for Sc mRNAs [136] enabled determination of the median Sp half-
life relative to Sc (Supplementary Figures S2 [187]). We measured growth curves, and obtained a
doubling time of 90 minutes for Sc in YPD medium at 30°C and 116 minutes for Sp in YES medium
at 32°C (Supplementary Figures S3 [187]). These doubling times were used in kinetic modeling
(Section II). We confirmed that the rates obtained by cDTA are essentially the same as the ones
previously obtained by DTA (Table 1, Supplementary Figures S2 [187]). RNA half-lives that were
recently determined by 4tU pulse-chase labeling in Sc are 1.5-fold longer [141], likely because a very
long labeling time was used that allowed for thionucleotide re-incorporation after mRNA decay.
We calculated mRNA synthesis rates as the number of complete transcripts made per cell and per
90 minutes (the cell cycle time for wild type Sc), using a new estimate of 60, 000 transcripts per
yeast cell [219], instead of the previously used, older and four-fold lower estimate [87]. For Sp, we
estimated the number of transcripts from the observed 2.51-fold cumulative total RNA level to be
150, 801. Our rate estimates are unaffected by the efficiency of 4tU labeling, which varies between
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Figure 44: (A) Determination of csp, the ratio of labeled over total Sp mRNA. To obtain absolute synthesis
and decay rates for Sc and Sp, we derived ratios of labeled to total RNA csc and csp for Sc and Sp, respectively.
The csc ratio was obtained in our previous study (Section 15). To determine csp, Lsc and Tsc are set to csc and
1, respectively. Lsp and Tsp are then linearly rescaled. The resulting Lsp/Tsp is defined as csp and then used
in the further experiments as global cDTA normalization factor. (B) cDTA normalization uses Sp signals as
internal standard. The bars indicate the median intensities of the array probe sets. Due to our experimental
design, the ratio of labeled to total Sp RNA (csp = Lsp/Tsp) must be the same in all experiments. To correct
for differences in cell lysis, RNA extraction efficiency, and RNA purification efficiencies, the levels of Sp total
and labeled mRNA are rescaled to the same values in all experiments. The Sc RNA levels are then corrected
by median centering of Sp RNA levels. This normalization allows for a direct comparison of Sc data between
experiments. Shown are both replicates for each of the four cDTA experiments.
strains and experiments (Supplementary Figures S1 [187]).
For normalization between different Sc samples, we linearly rescaled all array intensities such that
the total and labeled Sp fractions have a median intensity of 1 or cSp (Figure 44B). We assessed
the accuracy of the cDTA procedure by estimating the intensity ratios of Sc:Sp cells that were
mixed at 1:1, 3:1 and 10:1. The correct values were recovered with an accuracy of 5% (Figure
42C, 43). Selected mRNA levels of the 1:1 and 10:1 ratio mixtures were additionally quantified by
RT-qPCR (Section 20.4). The expected ratio of the four tested Sc transcripts was recovered within
a relative error of 9% when normalized to two housekeeping Sp genes (not shown). In summary,
cDTA normalization removes the major sources of experimental differences between samples in RNA
labeling efficiency, cell lysis, RNA extraction, RNA biotinylation and labeled RNA purification, and
array hybridization. cDTA detects global changes between Sc samples, in contrast to standard
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normalization procedures that eliminate global changes because they assume constant median RNA
levels.
Species cDTA DTA
Median mRNA Sc 12 11.5
half-life [min] Sp 59 N.A.
Median mRNA synthesis rate Sc 53a 18 (72)a
[mRNAs/cell/cell cycle time] a Sp 44 N.A.
Table 1: The cDTA contains the estimates obtained from using the labeled:total ratio of the complementary
strain and the known total and labeled Sc:Sp ratios to calculate the missing labeled:total ratio, i.e. LSc/TSc =
LSp/TSp · TSp/TSc · LSc/LSp. The DTA column shows the Sc half-life estimate obtained in Section 15.
Note that the Sc estimates are virtually identical to ours, although we used a different labeling technique
(4tU instead of 4sU) and had spiked-in Sp controls in the sample. aPlease note we previously used in our
calculations a total number of transcripts per cell of 15, 000, according to an old estimate [87], whereas we
now used a recent estimate of 60, 000 [219]. If the same number of transcripts is used, the median synthesis
rate obtained by DTA would be 72, comparable to our new estimate obtained by cDTA, despite the difference
in media and cell cycle time (Section 19.1).
16.3 cDTA supersedes conventional methods
Conventional methods measure mRNA half-lives by inducing transcription arrest and following
changes in mRNA levels over time. Transcription arrest has been achieved by adding the tran-
scription inhibitor 1,10-phenanthroline [53], or by shifting the temperature-sensitive mutant strain
rpb1-1, which carries a point mutations in the largest subunit of Pol II [148], to the restrictive tem-
perature [90, 205, 77, 176] (Section 3). To investigate whether the latter method yields reliable data
or whether it perturbs mRNA metabolism, we re-generated the rpb1-1 strain and analyzed it with
cDTA using published growth parameters [90] (Section 20.1). This revealed that mRNA synthesis
rates were decreased globally by a factor of 2.7 already at the permissive temperature of 30°C (Figure
45). After 24 minutes at the restrictive temperature, mRNA synthesis rates had decreased further
by a factor of 3.4, but recovered essentially to the rates measured at permissive temperature after
66 minutes (Figure 45).
These observations indicated that the mRNA metabolism in the rpb1-1 strain is already perturbed
at the permissive temperature, and that the temporary changes in mRNA metabolism observed at
the restrictive temperature are mainly due to a heat shock response. To test this, we conducted a
corresponding heat shock experiment on wild type cells. We analyzed the total mRNA from this
experiment together with the data from the rpb1-1 mutant by conventional decay time series analysis
[90, 205, 77, 176] (Section 3). The obtained mRNA half-lives during heat shock correlated very well
with data derived from the rpb1-1 mutant strain, and with published half-lives obtained with this
strain (Figure 46). The obtained half-lives were longer than the half-lives measured in unperturbed
cells, likely because mRNA degradation was down-regulated during the stress response. There was
also a good correlation with half-lives obtained after adding 1,10-phenanthroline, and even with
our previous data obtained during the osmotic stress response (Section 15.5), if processed in the
conventional way. This indicates that all these data are dominated by perturbations in mRNA
metabolism that result from a general stress response. In contrast, published half-lives derived from
metabolic RNA labeling [141] and our cDTA-derived half-lives do not correlate with data obtained
by perturbing conventional methods. We conclude that conventional methods for estimating mRNA
half-lives using the rpb1-1 mutant strain or transcription inhibition cannot be used to obtain reliable
half-life estimations.
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Figure 45: Box plots of the expression distributions of the total and the labeled (newly synthesized) mRNA
after cDTA normalization, obtained from the wild type and the rpb1-1 mutant before and 24 and 66 minutes
after the shift to restrictive temperature. Transcriptional activity is roughly restored in both strains after
66 minutes. The global shifts in labeled expression are only slightly more pronounced in the rpb1-1 mutant,
indicating a dominant role of heat shock in the profiles of rpb1-1.
16.4 Comparison of mRNA metabolism in distant yeast species
As an immediate result, cDTA reveals similarities and differences in the mRNA metabolism of Sc
and Sp. First, the median mRNA synthesis rates are very similar in Sc and Sp (Figure 47A). The
median synthesis rate was 53 mRNAs per cell and 90 minutes for wild type Sc and 44 mRNAs per
cell and 90 minutes for Sp. Second, Sp mRNAs have about five-fold longer half lives on average than
Sc mRNAs, with a median of 59 minutes (Figure 47A, Supplementary Figures S4 [187]), compared to
12 minutes for Sc. As expected, the cDTA-derived Sp half-lives show a fair correlation with half-lives
obtained by another non-perturbing metabolic labeling [6]. Furthermore, reprocessing the data of
[6] with our DTA algorithm, which takes into account the labeling bias and an additional parameter
to correct for cell growth, increases the correlation to our results and leads to a median half-live of
50 minutes, in good agreement with an estimate of 59 minutes in our study (Supplementary Figures
S2 [187]). Third, the overall mRNA levels in Sp were about 3.1-fold higher than in Sc. Since the
haploid Sc cells with a median volume of 42µm3 are approximately two- to threefold smaller than
Sp cells with a median cell volume of approximately 115µm3 [100, 146], the higher mRNA levels
apparently lead to similar cellular mRNA concentrations. The change in mRNA levels is mainly a
global multiplicative change (R2 = 0.82, Supplementary Figures S4 [187]). Taken together, these
data suggest that Sp cells generally contain more stable mRNAs than Sc cells to reach similar mRNA
concentrations at similar mRNA synthesis rates despite their larger volume.
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Figure 46: Correlation analysis of mRNA half-life measurements. The heatmap shows pair wise Spearman
correlation coefficients of half-life measurements (white: negative or zero correlation; purple: perfect correla-
tion). The published half-life estimates except for Munchel et al. [141] were obtained by experiments using
transcriptional arrest. The estimates of Holstege et al. [90], Wang et al. [205], Grigull et al. [77] and Shalem
et al. [176] were obtained using a yeast strain containing the Pol II temperature sensitive mutant rpb1-1.
Dori-Bachash et al. [53] used the transcription inhibitor 1,10-phenanthroline.
We investigated whether mRNA sequence conservation correlates with a conservation of total RNA
levels, synthesis rates, or decay rates (Figure 47B, Supplementary Figures S4 [187]). This analysis
revealed a conservation of the relative total levels of mRNAs that encode orthologous proteins in
Sc and Sp. The levels of mRNAs that encode proteins with an amino acid sequence identity of
at least 25% (2568 mRNAs) show a high Spearman correlation of 0.69. Synthesis rates correlate
well between both species (Spearman correlation 0.61), but the half-lives show only a fair correlation
(Spearman correlation 0.4). Although the data suggest that Sp cells have globally shifted decay rates,
to reach similar cellular mRNA concentrations, there is a minor fraction of transcripts that behave
exceptionally. In particular, 93 Sp transcripts show almost unchanged mRNA levels (< 1.5 fold),
but significantly higher synthesis and decay rates (> 1.5 fold), and are enriched for ribosomal protein
genes (Figure 47A). More generally, transcripts that encode highly conserved proteins show similar
levels, but a faster turnover in Sp (Figure 47B). We also assessed the correlation of synthesis rates
with transcript lengths, and revealed a substantially higher Pol II drop-off rate in Sp (Supplementary
Figures S5 [187]).
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Figure 47: (A) Scatter plot comparing mRNA decay rate folds versus synthesis rate folds of Sp and Sc
transcripts encoding protein orthologs (> 25% amino acid sequence identity). The offset of grey lines to par-
allel black lines indicate Sp:Sc ratios of median decay rates, synthesis rates, or total mRNA (0.20/0.83/2.72).
Dashed grey lines indicate 1.5-fold changes from the median (grey lines). Color scheme corresponds to folds
in total mRNA (magenta, positive log2 fold; green, negative log2 fold). A set of genes that show higher decay
and synthesis rates (1.5-fold & adjusted P-value 0.5%) but almost unchanged (< 1.5-fold) total mRNA (93
transcripts, striped area) was selected and tested with a Bayesian network-based gene set analysis (MGSA)
[15]. In this gene set, the ribosomal protein genes were enriched (blue dots; ellipse shows the 75% region
of highest density). (B) Plots show log2 fold distributions of total mRNA (grey), synthesis rate (red) and
decay rate (blue) of Sp versus Sc transcripts encoding orthologous proteins as a function of amino acid se-
quence identity (%). Transcripts encoding highly conserved proteins such as ribosomal proteins are located
on the right. They show more rapid turnover (synthesis and decay) in Sp, resulting in similar mRNA levels.
The solid black lines represent the median log2 fold, the shaded bands are the central 80% regions. The
solid/dashed grey lines indicate the median log2 fold of all orthologs/all genes.
16.5 Impaired mRNA synthesis is compensated by decreased degradation
We applied cDTA to the question of whether the speed of Pol II is relevant for setting the cellular rates
of mRNA synthesis. We used a yeast strain that carries the non-disruptive point mutation N488D in
the largest Pol II subunit Rpo21p (also known as Rpb1p) (rpb1-N488D). This mutation slows down
Pol II speed in RNA elongation assays in vitro [125] and is located near the active site [45]. We
subjected this strain and an isogenic wild type strain to cDTA, and collected two biological replicates,
which showed a Spearman correlation of 0.99 for total and labeled RNA (Supplementary Figures S6
[187]). We measured cell-doubling times, and used these in the kinetic modeling, to correct synthesis
rates for a change in doubling time (Supplementary Figures S3 [187]). In the rpb1-N488D mutant
strain, mRNA synthesis rates were globally decreased 3.9-fold (Figure 48A). This is consistent with
the observed 2- to 4.5-fold decrease in Pol II speed measured in vitro [125]. We observed a Pol II
drop-off rate similar to that described previously [99], but quantitative modeling excludes drop-off
80
of Pol II during elongation as the cause for the decreased synthesis rates (Supplementary Figures S7
[187]).
Figure 48: (A) Linear scatter plots (heat-colored) of mRNA synthesis rates, decay rates, and total mRNA
levels in wild type and mutant rpb1-N488D yeast strains as measured by cDTA. Slopes indicate global shift
ratios of median synthesis rates, decay rates, and total mRNA of the rpb1-N488D mutant strain compared to
wild type (0.26/0.31/0.75). (B) Alternative representation of the data from panel A in a single scatter plot
comparing the changes in mRNA synthesis rates (log2 folds, x-axis) and decay rates (log2 folds, y-axis) in
the rpb1-N488D mutant strain compared to the wild type strain. Each point corresponds to one mRNA. The
density of points is encoded by their brightness (grey scale). Contour lines define regions of equal density.
The center of the distribution is located at (−1.8,−1.6), indicating that there is a global shift in the median
synthesis rate by a factor of 0.26 (shift of the horizontal red line relative to the dashed x-axis line), and a
global shift in the median decay rate by a factor of 0.31 (shift of the vertical red line relative to the dashed y-
axis line). The global change in total mRNA levels is predicted by the offset of the diagonal red line from the
dashed main diagonal, which corresponds to a change by a factor of 0.75. The number in brackets following
this number (0.75) is the global change as it has been observed in the total mRNA measurements, which
agrees well with the predicted number. The changes in total RNA levels do not exactly equal the quotient
of synthesis and decay rate changes, due to an additional parameter for cell growth. (C) Scatter plots as in
(B) comparing synthesis rates, decay rates, and total mRNA levels of Δccr4 and Δpop2 mutant strains to
wild type yeast. Ratios of median synthesis rates, decay rates, and total mRNA of the Δccr4/Δpop2 mutant
strain compared to wild type are 0.49/0.39, 0.43/0.16, and 1.15/1.74, respectively.
Despite the lower synthesis rates, global mRNA levels were not changed very much in the slow Pol
II mutant strain (Figure 48A). This resulted from a strong decrease in mRNA decay rates of 3.2-fold
on average. Synthesis and decay rates of all mRNAs were shifted by approximately the same factor,
independent of their wild type expression level, synthesis rate, or decay rate. The globally increased
mRNA half-lives apparently compensated for the decreased mRNA synthesis rates, to buffer cellular
mRNA levels, which were decreased 1.3- fold only (Figure 48B). The measured total RNA levels
agreed well with total mRNA levels calculated from the changed synthesis and decay rates (not
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shown). These results show that cells with a strong defect in mRNA synthesis can maintain nearly
normal mRNA levels by compensatory changes in mRNA decay rates.
16.6 Impaired degradation is compensated by decreased synthesis
The observed synthesis-decay compensation implies that cells buffer total mRNA levels. If true, cells
should also be able to compensate for a mutation that impairs mRNA degradation with a change
in mRNA synthesis rates. To investigate this, we applied cDTA to mutant yeast strains with global
defects in mRNA degradation. The choice of mutant was difficult, since RNA degradation involves
multiple enzymes in the nucleus and cytoplasm (Section 1.2) [91]. We decided to use mutant strains
that lack either one of the two catalytic subunits of the Ccr4-Not complex, Ccr4 or Pop2, which show
a defect in mRNA deadenylation, a rate-limiting step in mRNA degradation [194]. As predicted,
mRNA decay rates were globally decreased in the Dccr4 and Dpop2 strains, and changed on average
by a factor of 0.43 and 0.16, respectively (Figure 48C). This suggests that Ccr4 and Pop2 mRNA
degradation factors are used globally.
In both degradation-deficient knock-out strains, an unexpected decrease in mRNA synthesis rates
was observed (Figure 48C). Synthesis rates were changed by a factor of 0.49 and 0.38 in the Dccr4
and Dpop2 strains, respectively, limiting the increase in total mRNA levels due to highly defective
degradation to a factor of only 1.18 and 1.75, respectively (Figure 48C). This effect could be observed
directly in the labeled fractions of the Dccr4 and Dpop2 strains. Only 62% or 46% of the RNA
was labeled within the same labeling time, indicating lower synthesis rates. Thus the defects in
RNA degradation in these strains are at least partially compensated by decreased mRNA synthesis
rates, to buffer mRNA levels. This mutual compensation cannot be explained by measurement
variance. A variation analysis for the estimation of the median synthesis and decay rates (Figure 49,
Supplementary Methods S9 [187]) shows that the 95% confidence regions of the median synthesis
and decay rate estimates are clearly disjoint.
Figure 49: Coupling of synthesis and decay rates, on the absolute level. For each condition, the median
synthesis rate (y-axis) and degradation rate (x-axis) is shown (dark dots). Dashed lines indicate fold induc-
tion/repression relative to wild-type. The dots lie approximately on a line with positive slope, indicating
synthesis-decay compensation. A variation analysis for the estimation of the median synthesis and decay
rates with cDTA has been performed. The ellipses show the 95% bootstrap confidence regions in each con-
dition. The main axes of the ellipses reveal that the errors in the estimation of synthesis and decay rates are
not independent, yet small enough to prove that the coupling is not due to estimation variance.
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16.7 cDTA reveals different in vivo 4tU labeling and incorporation efficiency
upon mutation
We can use cDTA to compare 4tU labeling and incorporation efficiencies across different strains.
We define three probabilities associated with mRNA labeling process: The incorporation efficiency
is the probability that a 4sUTP nucleotide is incorporated into a nascent mRNA instead of a UTP.
Secondly, the capture efficiency is the probability for a 4sUTP nucleotide which is included into a
mRNA of being biotinylated, captured and recovered from the streptavidin-coated magnetic beads.
Third, the probability that both events occur, assuming independence, is the product of the in-
corporation efficiency and the capture efficiency. We refer to this as the labeling efficiency. Since
the labeled Sc and Sp RNA from one sample are processed simultaneously, the capture efficiency
equals each other for that sample. Moreover, the incorporation efficiency for Sp should also equal
each other across different conditions, since we use a common Sp standard for all experiments. This
circumstance then allows us to conclude to the relative incorporation efficiency between a mutant
and wild-type strain (Section 11.6). It turns out that the relative incorporation efficiency is less
than 1 for all three mutants considered by us (Table 2).
rpb1-N488D Dccr4 Dpop2
0.51± 0.07 0.49± 0.05 0.71± 0.08
Table 2: Relative incorporation efficiencies were estimated as described in Section 11.6, standard deviations
were calculated using replicate measurements.
16.8 Summary & Outlook
A systemic investigation of gene expression requires quantitative monitoring of cellular mRNA
metabolism. In particular, a technique is required to quantify absolute mRNA synthesis and decay
rates on a genome scale upon genetic perturbation. Here we provide such a technique that we re-
fer to as comparative Dynamic Transcriptome Analysis (cDTA). cDTA is based on non-perturbing
metabolic RNA labeling in mutant and wild type budding yeast cells, and the use of fission yeast
cells as an internal standard. cDTA is a non-perturbing method for monitoring mRNA turnover
and supersedes conventional methods, which require transcription inhibition, resulting in a stress
response and perturbation of mRNA metabolism.
cDTA improves our previous DTA protocol (Section 15) [136] in several respects. First, cDTA
provides reliable estimates of the absolute synthesis and decay rates, thereby allowing for a direct
comparison of rates between different yeast strains. Second, cDTA uses 4tU instead of 4sU for
RNA labeling, allowing for standard media and abolishing the need for a nucleoside transporter.
Third, cDTA requires only two instead of three microarray measurements per rate estimation. As
an immediate result, cDTA revealed that Sp and Sc cells have similar synthesis rates, but Sp RNAs
have about five-fold longer mRNA half-lives, leading to similar cellular mRNA concentrations despite
a different cell volume.
Application of cDTA to Sc cells expressing a Pol II point mutant that elongates mRNA slowly
in vitro showed that mRNA elongation is a critical determinant for mRNA synthesis in growing
cells in vivo. It also revealed that cells compensate for low synthesis rates by lowering decay rates,
thus stabilizing mRNAs and buffering their levels. Application of cDTA to two mutant strains that
lack either one of the two catalytic subunits of the mRNA deadenylase complex Ccr4-Not showed
not only the expected defect in mRNA degradation but also a compensatory decrease in mRNA
synthesis, also leading to a buffering of mRNA levels. This indicated the existence of a feedback
loop that connects mRNA synthesis and degradation, and serves to buffer mRNA levels. These
results support published evidence for a global control of mRNA levels in dependence of cell size
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[220]. This global control of mRNA levels occurs despite the separation of mRNA synthesis and
degradation into nuclear and cytoplasmic compartments.
The mechanisms underlying the synthesis-decay feedback loop and the buffering of mRNA levels
are unclear. The feedback loop may be a result of a physical and functional coupling between the
various parts of mRNA metabolism. Transcription is coupled to mRNA processing and export [127],
and translation is coupled to mRNA degradation [40, 22, 41, 93]. There is also evidence that nuclear
and cytoplasmic mRNA metabolism are linked. The Pol II subcomplex Rpb4/7 shuttles between
the nucleus and cytoplasm [175], and is involved in transcription [54] and mRNA translation and
degradation [122, 123, 82]. The Ccr4-Not complex is involved in mRNA degradation [194], but also
in transcription [119, 38, 39, 108].
84
17 DTA as a tool for miRNA target validation in D.melanogaster
In most cases, miRNAs target mRNAs with only partial sequence complementarity (Section 1.3).
The limited sequence complementarity can lead to a large number of different mRNA targets regu-
lated by a single miRNA [173, 9]. The seed region (∼ 8 nucleotides) can be sufficient for a productive
interaction. This complicates the reliable prediction of miRNA - target mRNA interactions. Many
mRNAs can in principle be regulated by a given miRNA in silico [184, 23, 107, 115, 163, 65, 13].
Consequently, at least 30% of all protein coding genes in animals are predicted to be regulated by
miRNAs. miRNAs predominantly act as negative post-transcriptional regulators of gene expression
[4, 14, 197], i.e. repress the translation or stimulate the degradation of their target mRNAs. It
is however questionable, that such a large number of mRNAs is actually repressed by the respec-
tive miRNA [172], which requires the need for experimental validation. To that end, we applied
DTA (Section 4) to measure transcriptional and post-transcriptional effects by miR-277, a miRNA
that is expressed endogenously in D.melanogaster Schneider cells (S2-cells). 2’-O-methyl antisense
oligonucleotides were used to inhibit miR-277 [96] for three days. Subsequently, the mRNA was
pulse-labeled for 60 minutes and analyzed by DTA.
Figure 50: Volcano plots compare total and labeled mRNA levels upon inhibition of miR-277 after 60 min
labeling versus reference cells treated with a control oligo. An inhibitor with an unrelated sequence (part of
the luciferase gene) served as a control. Each dot corresponds to one gene, the x axis displays the log2(fold)
of that gene, the y axis represents the P-value (without FDR correction, see Section 18.3). 10 out of 14
significantly up-regulated genes in the total mRNA fraction are predicted miR-277 targets (depicted in red).
In contrast, the labeled mRNA fraction showed only 1 predicted miR-277 target as significantly up-regulated.
17.1 Inhibition of miR-277 reveals genuine target mRNAs
Inhibition of miR-277 should increase steady-state mRNA levels of its target mRNAs. Changes in
mRNA degradation rate can be detected in the unlabeled or total mRNA fraction, whereas synthesis
rate changes should be visible in the labeled fraction of the mRNA. No genes were detected as
significantly differentially expressed with FDR correction (Section 18.3), so it was omitted for the
microarray analysis. Without FDR correction, 14 genes were significantly up-regulated in the total
mRNA fraction. 10 of these genes are predicted miR-277 targets (Figure 50, Table 3). On the
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contrary, the labeled mRNA fraction showed only 1 predicted miR-277 target as significantly up-
regulated.
gene total RNA unlabeled RNA (>1 hr) labeled RNA (<1 hr) pred. target
CG8199 1.51 1.73 n.s. yes
CG5599 1.67 1.69 n.s. yes
CG15093 1.17 1.01 n.s. yes
CG3267 1.11 1.24 n.s. yes
CG2118 1.65 1.93 0.72 yes
CG5044 0.63 0.55 n.s. yes
CG6984 0.87 1.19 n.s. yes
CG6543 1.25 1.25 n.s. yes
CG9867 0.65 0.70 n.s. yes
CG4594 0.84 n.s. n.s. yes
Table 3: 10 predicted targets were significantly up-regulated in the total mRNA fraction upon inhibition of
miR-277. Table shows the log2-fold of these target mRNAs after inhibition of miR-277 against a reference
treatment with a control oligo. Microarray analysis to detect significantly differentially expressed mRNAs
upon inhibition of miR-277 was done without FDR correction (Section 18.3). Significant changes however
appear to be present in the total as well as the unlabeled mRNA fraction.
miR-277 has 691 predicted mRNA targets in the targetscan database (version 6.1) [167]. 358 of
these are detected as expressed in our S2-cell microarray analysis but only 10 showed significant
up-regulation upon inhibition of miR-277. Most of the predicted miR-277 targets could thus not be
validated by us, which might be due to unreliable predictions of miRNA - target mRNA interactions.
The small seed region may lead to false positive mRNA target annotations.
17.2 Summary & Outlook
Predictions of miRNA - target mRNA interactions requires experimental validation as in silico
prediction tools often bear false positive mRNA target annotations. Transcriptomic validation of
targets of a certain miRNA was up to now limited by indistinguishable direct and indirect miRNA-
mediated effects. We exemplified DTA as a valuable tool for direct miR-277 target validation in
D.melanogaster and proved that such an analysis is possible. It may also be a valuable choice for
other miRNAs. Additionally, it allows for the separation of indirect from direct effects. Only direct
effects are characterized by changes in mRNA stability. Given that DTA is in principle not limited to
D.melanogaster, we suggest it as a useful strategy for target identification and validation of miRNAs
in other organisms.
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Part IV
Conclusion
Technological advances in experimental techniques as well as the availability of DNA se-
quences of whole genomes enable to study biological questions at a global level and so far
unreached complexity and detail. The field of computational biology is thus challenged to
develop new approaches and efficient algorithms to gain new insights into the underlying
biological systems of large scale data sets from high-throughput methods.
In this thesis, we focused on a systemic investigation of gene expression via quantitative
monitoring of cellular mRNA metabolism. In particular, we developed a novel method to
quantify absolute mRNA synthesis and decay rates on a genome-wide scale upon genetic
perturbation (DTA/cDTA). DTA/cDTA is based on non-perturbing metabolic RNA label-
ing in mutant and wild type budding yeast cells. Fission yeast cells are used as an internal
standard. DTA/cDTA is a new experimental approach to simultaneously measure the con-
tributors of mRNA turnover in one single experimental setting. This can be achieved in a
noninvasive manner with a superior accuracy compared to previous methods, which require
transcription inhibition and thereby perturb mRNA metabolism. In this way, significant
changes in mRNA synthesis are observed in newly transcribed mRNA before they have a
visible effect on total cellular mRNA. DTA/cDTA is capable of monitoring kinetic parameter
changes accurately even during dynamic cellular responses to environmental stimuli, and it
does so at a higher sensitivity and temporal resolution than standard transcriptomics. It is a
highly valuable tool that can provide quantitative data for modeling complex gene-regulatory
systems, which is needed to provide new insights and to uncover misleading drawbacks of
traditional methods. It could be used to characterize gene expression programs under defined
conditions, and to analyze the influence of changes in environmental conditions on mRNA
turnover. Further, DTA/cDTA could be used to decipher the pathways of mRNA decay and
the global regulation of mRNA half-lives by RNA-binding proteins.
DTA/cDTA is provided with a statistical methodology and all required bioinformatics steps
that allow the accurate absolute quantification and comparison of mRNA turnover. The
bioinformatic workflow of DTA/cDTA is implemented in the open source R/Bioconductor
package DTA [170] as a part of this thesis. The DTA package delivers straightforward meth-
ods to estimate RNA synthesis and decay rates from pre-processed microarray or RNASeq
measurements obtained via the DTA/cDTA protocol. DTA fulfills the high standards of the
Bioconductor platform, regarding documentation and usability. Therefore, it is easily incor-
porated in R scripts for pre-processing. Further statistical analysis of the results can readily
be carried out by other methods within the R/Bioconductor programming environment.
To deal with rapid advances in high-throughput techniques, bioinformatic approaches will
always have to be applied and adapted to progress and improvements of new experimental
techniques. It should further be considered whether more complex models can further increase
the prediction accuracy.
DTA/cDTA can be applied to reveal rate changes for all kinds of perturbations, e.g. knock-
out or point mutation strains, responses to stress stimuli or small molecule interfering assays
like treatments with miRNA or siRNA inhibitors. In doing so, DTA was shown to be a
valuable tool for miRNA target validation. The DTA/cDTA approach is in principle ap-
plicable to virtually every organism in which a labeling approach can be established. This
covers labeling with 4sU, 4tU as well as 5’-bromo-uridine, one of the new emerging methods
(BRIC-seq) [190].
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Part V
Appendix
18 Statistical methods
18.1 LOcal Polynomial RegrESSion Fitting
LOESS, or LOWESS (locally weighted scatterplot smoothing) [204, 34] allows to fit a smoothed
polynomial surface resp. curve to n-dimensional data. At each data point x a polynomial of low
degree is fitted to a subset of the data (neighborhood of x). The size of the neighborhood can be
controlled by a parameter α (defaults to α = 0.75 of all the data points). The polynomial is fitted
by means of a weighted least squares regression [19], weighted to lower the influence of data points
with the largest residuals. The value of the dependent variable f(x), i.e. evaluation of the local
polynomial using the independent explanatory variable values, is then assigned to the data point x.
The degree of the polynomial is usually 1 or 2. The described method is implemented in the stats
package in R [160] and was used within this environment.
18.2 Methods of moments for gamma Γ distributed sample populations
The method of moments is commonly used to estimate the population parameters of a certain
distribution by equating the sample moments with the unobservable population moments. It is based
on the assumption that the sample moments converge to the population moments of the underlying
distributions if the number of observations N → ∞ [217, 44, 135, 19]. Suppose X1, ... , XN are
independent identically distributed random variables that follow a gamma distribution with shape
k and scale θ:
X1, ... , XN ∼
iid
Γ(k, θ) (142)
The first moment - the expected value - is then given as
E(X1) = kθ (143)
and can be approximated as the first sample moment with
m1 =
X1 + · · ·+XN
N
(144)
The second moment - the expected value of its square - can be stated as
E(X21 ) = θ
2k(k + 1) (145)
and can be approximated as the second sample moment with
m2 =
X21 + · · ·+X2N
N
(146)
Given Equation (144) and (146), the population parameters k and θ can be calculated as
k =
m21
m2 −m21
(147)
and
θ =
m2 −m21
m1
(148)
based on the observed samples. Note that E(X1)2 − E(X21 ) = V ar(X1) = θ2k .
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18.3 Detection of differentially expressed genes
We eventually aim to identify genes that behave differently in the comparison of two groups of
genome-wide measurements, be it total mRNA levels, labeled mRNA levels, or synthesis rates.
The problem of identifying differentially expressed genes in microarray experiments with arbitrary
numbers of groups and mRNA samples was considered by Gordon K. Smyth [181]. His model is
formulated as a linear regression problem. The estimators proposed show robust behavior even for
small numbers of arrays. The approach is implemented in the R/Bioconductor package LIMMA
[181], which can be used after appropriate normalization of the used expression profiles (see Section
18.4). Multiple testing correction is done by converting p-values into local false discovery rates [17].
We consider a gene significantly differentially expressed if it achieves a local false discovery rate
smaller than 5% in the respective two-group comparison. The effect of induction/repression is called
relevant if the mean expressions of the two groups differ by a factor of at least 2. A gene is called
induced/repressed if it is significantly and relevantly up-/down-regulated relative to the reference
group.
18.4 Baseline normalization
Variations in mRNA extraction efficiencies, amplification steps in the biochemical protocol and scan-
ner calibration of the fluorescence readouts introduce slight differences in the global spot intensity
levels on the microarrays. This problem is often solved by centering the medians of the respective
expression profiles to a common value [20], often referred to as baseline normalization.
Let G be the set of genes that were measured on the arrays A. The measured gene expression of gene
g ∈ G on a microarray a is denoted by Fga. We further set ma = median{Fga | g ∈ G}, the median
of the microarray a. Each microarray (Fga)g∈G is rescaled such that median{Fga | g ∈ G} = m,
where m = median{ma | a ∈ A} is the median of the median intensities. Namely
Fga is replaced by
Fga ·m
median{Fga | g ∈ G}
for all a ∈ A .
This is only reasonable though, if the assumption can be met, that the global level of expression
has not changed. In our DTA/cDTA procedure however, this is not necessary for rate extraction.
Proportional rescaling of expression profiles is completely compensated by the total least squares
regression, which is a feature of our estimation procedure (Section 11.3). For cDTA, it is in fact
only required once to calibrate all microarrays to yield the respective absolute median half-life of
the wild-type reference (Sections 4.3, 16). Given global changes in total mRNA levels, synthesis or
decay rates, as they can be revealed by cDTA, centering the medians of the respective profiles to a
common value, is a reasonable approach for further investigation of differential behavior of certain
genes referring to the majority of the genes. This can be addressed by considering the internal
ranking or the by detecting differential expression (Section 18.3) to find intra-differential expressed
transcripts, i.e. differential behavior referring to the majority of the genes, and hence regulation
that is independent of changes in the global level.
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19 Materials and methods for Section 15
19.1 RNA labeling and microarray analysis
We used S. cerevisiae strain BY4741 MATa, his2D1, leu2D0, met15D0, ura3D0 (Euroscarf). The
strain was transformed with plasmid YEpEBI311 (2µm, LEU2 ) carrying the human equilibrative
nucleoside transporter hENT1. Samples for establishing DTA were grown in SD medium overnight,
diluted to an OD600 of 0.1 the next day and grown up to a mid-log phase (a final OD600 of 0.8
corresponding to 1.75 · 107 cells per ml). 4sU (Sigma) was added to the media and made up to
a final concentration of 500µM, and cells were harvested after different labeling times. Cells were
centrifuged at 4000 r.p.m. for 1 min and pellets were flash-frozen in liquid nitrogen. Samples
for quantitative RT–PCR and for salt-stress experiments were grown in SILAC medium lacking
leucine (6.7 g/l Formedia yeast nitrogen base without amino acids, 2% glucose, 2% agar, 200 mg/l
adenine, 200 mg/l tyrosine, 10 mg/l histidine, 10 mg/l methionine, 60 mg/l phenylalanine, 40 mg/l
tryptophan, and 20 mg/l uracil) overnight, diluted to an OD600 of 0.1 the next day and grown up
to a final OD600 of 0.8. Cells were harvested 0, 6, 12, 18, 24, 30, and 36 min after addition of
NaCl up to a final concentration of 0.8 M. Other steps were as above. Total RNA was extracted
with the RiboPure-Yeast Kit (Ambion/Applied Biosystems), following the manufacturer’s protocol.
Labeled RNA was chemically biotinylated and purified using strepatavidin-coated magnetic beads
as described [52]. Labeling of samples for array analysis was performed using the GeneChip 3’IVT
labeling assay (Affymetrix) with 100 ng input RNA. Samples were hybridized to GeneChip® Yeast
Genome 2.0 Array following the instructions from the supplier (Affymetrix®). Quality control and
array processing was done using GCRMA [213] for expression quantification and LIMMA [182] for
elementary array comparisons (Supplementary Sections 12.1–12.5 [136]).
19.2 Pol II in vitro transcription
To determine the incorporation efficiency of 4sUTP by Pol II, we performed in vitro RNA extension
assays with reconstituted elongation complexes containing a synthetic nucleic acid scaffold with
an adenine base in templating position +1 and +2 (Scaffold A, [189]). The assembled ECs were
incubated with 0.002, 0.01, 0.05, 0.25, or 1.25µM of 4sUTP or UTP. Reactions were stopped at
10 min and product RNAs were separated by gel electrophoresis and quantified with a fluorimager.
Lineweaver-Burk plots were used to analyze Michaelis-Menten kinetics KM values of 13 nM and 3
nM for 4sUTP and UTP, respectively, but the same rate constant kcat. Bead-based assays were as
described [49, 189].
19.3 mRNA decay analysis by RT–PCR
mRNA levels were determined for eight genes: ACT1 (YFL039C), CTT1 (YGR088W), GPD1
(YDL022W), KSS1 (YGR040W), RDN1 (rRNA locus), SFG1 (YOR315W), STL1 (YDR536W),
and TUB2 (YFL037W). The experiment was performed in two steps. Step 1 was performed un-
der normal growth conditions whereas step 2 was performed the same way after addition of 0.8 M
NaCl. mRNA levels were analyzed at 0, 2.5, 6, 10, and 16 min after addition of 1,10-phenanthroline
(100µg/ml final concentration) and at 0, 12, 30, and 36 min. 4sU labeling was carried out for
6 min at a final concentration of 500µM (Supplementary Figure S3 [136]). RNA was extracted
as above. cDNA synthesis was performed with 500ng RNA originating from total, unlabeled and
labeled mRNA using the iScript cDNA Synthesis Kit (BioRad). Primers were designed with the
ProbeFinder software (Roche Applied Science) and individual primer-pair efficiency was tested and
ranged between 95 and 100%. Sequence information of primer pairs used in this study is available
upon request. PCR reactions contained 1µl DNA template, 2µl of 10µM primer pairs, and 12.5µl
SsoFast EvaGreen Supermix (BioRad). Quantitative RT–PCR was performed on a Bio-Rad CFX96
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Real-Time System (Bio-Rad Laboratories Inc.) using a 3 min denaturing step at 95°C, followed by
49 cycles of 30s at 95°C, 30s at 61°C, and 15s at 72°C. Threshold cycle (Ct) values were determined
by application of the corresponding Bio-Rad CFX Manager software version 1.1 using the Ct deter-
mination mode ‘Regression’. Two biological and three technical replicates were used for each time
point and technical variance was minimized using in-plate controls.
19.4 Genomic occupancy profiling
For genomic occupancy profiling by ChIP-chip, we used S. cerevisiae strain BY4741 containing a C-
terminal tandem affinity purification (TAP) tag on the Pol II subunit Rpb3 (Open Biosystems).We
confirmed that the TAP tag was at the correct genomic position, that the tagged Rpb3 subunit was
expressed, and that the strain grew normally at 30°C. Yeast cells were grown in YPD medium until
exponential phase (OD600 v 0.8) and then stressed by the addition of 0.8 M NaCl. ChIP-chip was
performed for biological replicates 0, 12, and 24 min after salt addition with high-resolution tiling mi-
croarrays as described in [129]. The bioinformatics analysis has been done using the R/Bioconductor
software package Starr [218], see (Supplements, Part II, Section 16–18 [136]).
19.5 Accession codes
Microarray data were deposited in ArrayExpress under accession code E-MTAB-439.
19.6 Supplementary information
Supplementary information is available at the Molecular Systems Biology website
http://www.nature.com/msb/journal/v7/n1/suppinfo/msb2010112_S1.html.
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20 Materials and methods for Section 16
20.1 Yeast strains and growth curves
Strains RPB1 and rpb1-N488D (GRY 3020 and GRY 3027 respectively) were generously provided by
Mikhail Kashlev [125]. Genotypes of GRY 3020 and GRY 3027 are MATa, his3D1, leu2D0, lys2D0,
met15D0, trp1D::hisG, URA3 ::CMV-tTA RPO21 and MATa, his3D1, leu2D0, lys2D0, met15D0,
trp1D::hisG, URA3 ::CMV-tTA rpb1-N488D. For cDTA we used Sc wild type strain BY4741 MATa,
his2D1, leu2D0, met15D0, ura3D0 (Euroscarf) and the isogenic knockout Dpop2 and Dccr4. Dpop2
was from the YKO library (OpenBiosystem) and Dccr4 was generated by substituting the target
gene for a KanMX cassette using homologous recombination in the same genetic background [121].
The rpb1-1 (rpb1-G1437D) strain and isogenic wild type strain were generated in our lab. Plasmids
pRS316-RPO21, pRS315-RPO21 and pRS315-rpb1-1 were generated by cloning the respective ORF
or mutant ORF plus sequences 500 bp upstream and 250 bp downstream into pRS316 (ATCC) and
pRS315 (ATCC) using XhoI/SacI restriction sites. The heterozygous RPO21/rpo21D Sc yeast
strain (BY4743, rpo21 ::KanMX6/RPO21 ) was generated and transformed with pRS316-RPO21.
Diploids were sporulated and tetrads dissected on YPD plates. After transformation of the shuffle
strains with pRS315-RPO21 or pRS315-rpb1-1, the resulting strains were streaked twice on 5-FOA
plates and then on SC-Leu. Sp strain FY2317 h+, leu1-32::hENT1-leu1+(pJAH29) his7-366::hsv-
tk-his7+(pJAH31) ura4-D18 ade6-M210 [88] was kindly provided by Susan Forsburg. YPD medium
was inoculated with a single Sc colony. Sp was grown in YES medium. The culture was grown
to stationary phase overnight and diluted to OD600 = 0.1. Measure points were taken every hour
before OD600 reached 3. Additional time points were taken until stationary phase was reached.
Doubling time was calculated by fitting the log-transformed values of OD600 into a linear function.
20.2 Comparative Dynamic Transcriptome Analysis (cDTA)
Sc cells were grown in YPD medium overnight, diluted to an OD600 of 0.1, and grown to midlog
phase. OD600 of 0.8 corresponded to 1.75 ·107 cells per ml. 4-thiouracil (4tU, Sigma, 2M in DMSO)
was added to the media at a final concentration of 5mM, and cells were harvested after 6 minutes
of labeling by centrifugation at 2465×g 30°C for 1 minute. The supernatant was discarded and the
pellet re-suspended in RNAlater solution (Ambion/Applied Biosystems). The cell concentration was
determined by Cellometer N10 (Nexus) before flashfreezing in liquid nitrogen. Sp cells were grown
in YES medium overnight, diluted to OD600 = 0.1 and grown to OD600 = 0.8. 4sU was solved in
ddH2O (50mM) and added to a final concentration of 500µM and cells were labeled for 6 minutes.
Cells were harvested by centrifugation at 2465×g for 3 minutes. Other steps were as above. A 4l
culture of Sp cells was labeled to generate a stock and eliminate errors by variations in the standard.
Cells were counted as above. Sp cells were mixed with Sc cells in a 1:3 ratio, resulting 4 · 108
cells in total. Total RNA extraction, labeled RNA purification as well as sample hybridization and
microarray scanning were as previously described [136]. For the cDTA analysis of rpb1-1 strains,
overnight cultures were diluted in fresh medium to OD600 of 0.15 (125ml cultures, 160rpm shaking
incubator, 30°C). At OD600 of 0.9 (time point −18 min) RNA was labeled. 18 minutes later (time
point 0 min) cultures were shifted to 37°C by adding the same volume of 42°C-tempered medium.
RNA was again labeled 18 minutes and 60 minutes after heat shock (time points +24 min and +66
min, respectively).
20.3 cDTA data analysis
Data was pre-processed array-wise using expresso (R/Bioconductor [160, 71]) with the RMA back-
ground correction method [213]. We created our own probe annotation environment (cdf), which
excludes probes in probesets that show cross-hybridization between Sc and Sp. 8708 annotated Sc
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probes and 13, 317 annotated Sp probes out of a total of 120, 855 probes showed cross-hybridization
when a conservative intensity cut-off of 4.5 (log(intensity) values after pre-processing) was used.
Cross-hybridizing probes were excluded from further analysis. This included 16 whole probe sets
(Fig. 42A, see Supplementary Figures S1 [187]). Note that the standard GC-RMA method is not
suitable for our purposes, since its bias model cannot handle bimodal intensity distributions, as
caused by the simultaneous hybridization of Sc and Sp transcripts with global differences in RNA
abundance (Fig. 43). Labeling bias estimation and correction was done as described (Section 11.1).
Between-array normalization of arrays containing mixed Sc and Sp total RNA was done by pro-
portional rescaling, such that the median Sp gene expression level was 1 (Fig. 44B). Accordingly,
between-array normalization of arrays containing mixed Sc and Sp labeled RNA was done by pro-
portionally scaling the array to a median labeled Sp gene expression level of cSp (Fig. 44A). The
constant cSp scales the median half-life of all experiments. We calibrated cSp in a way that the
resulting median Sc wild type mRNA half-life equaled that observed previously (Section 15, Table
1). Now, all Sc RNA levels, no matter if total or labeled, no matter from which experiment, can be
compared on an absolute level. Decay rates and synthesis rates were obtained as described (Section
II). We assume that the labeled RNA fraction is subject to degradation from the very time it is
synthesized. In contrast, Rabani et al. 2011 [161] (Supplementary Methods therein) assume that
the labeled RNA fraction is mostly nuclear and not degraded at all. We compared the synthesis rate
estimates resulting from both alternatives (Supplementary Methods S9 [187]). Given our labeling
time, the differences of both approaches are negligible. The whole analysis workflow has been carried
out using the open source R/Bioconductor package DTA (Section 6) [170].
20.4 RT-qPCR
Sp and Sc cells were grown to OD600 = 0.8, harvested and flash-frozen in liquid nitrogen. Cells
were counted and mixed at 1:1 and 10:1 ratios. Total RNA was extracted, and the mRNA levels of
Sc genes ACT1 (YFL039C), ADH1 (YOL086C), HIS4 (YCL030C), and Rdn1 (rRNA locus) and Sp
genes GDI1 (SPAC22H10.12c) and GPD1 (SPBC215.05) were determined by RT-qPCR. RT-qPCR
was carried out as described (Section 19.3). 500ng RNA was used to reverse transcribe cDNA using
the iScript cDNA Synthesis Kit (BioRad). Primers were designed with the ProbeFinder online tool
(http://qpcr.probefinder.com/organism.jsp, Roche Applied Science). The primer-pair efficiency was
tested individually and ranged between 97 and 100%. PCR reactions contained 1µl DNA template,
2µl of 10µM primer pairs, and 12.5µl SsoFast EvaGreen Supermix (BioRad). qPCR was performed
on a Bio-Rad CFX96 Real-Time System (Bio-Rad Laboratories Inc.) using a 30 sec denaturing
step at 95°C, followed by 40 cycles of 1s at 95°C, 4s at 63°C. Data analysis was performed with the
software Bio-Rad CFX Manager 1.6.
20.5 Accession codes
Microarray data were deposited in ArrayExpress under accession codes E-MTAB-760.
20.6 Supplementary information
Supplementary information is available at the Genome Research website
http://genome.cshlp.org/content/early/2012/04/16/gr.130161.111/suppl/DC1.
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